scientific journal | Q5633421 |
P6981 | ACNP journal ID | 44194 |
P8375 | Crossref journal ID | 44899 |
P1250 | Danish Bibliometric Research Indicator (BFI) SNO/CNO | 10556 |
P5963 | Elsevier journal ID | clinics-in-laboratory-medicine |
P8903 | HAL journal ID | 22450 |
P236 | ISSN | 0272-2712 |
1557-9832 | ||
P7363 | ISSN-L | 0272-2712 |
P1277 | JUFO ID | 53657 |
P1055 | NLM Unique ID | 8100174 |
P856 | official website | http://home.mdconsult.com |
http://www.clinicalkey.com.au/dura/browse/journalIssue/02722712 | ||
http://www.clinicalkey.com/dura/browse/journalIssue/02722712 | ||
http://www.mdconsult.com/public/search?search_type=clinics&j_sort=pub_date&j_issn=0272-2712 | ||
https://www.journals.elsevier.com/clinics-in-laboratory-medicine | ||
P10283 | OpenAlex ID | S139467280 |
P3181 | OpenCitations bibliographic resource ID | 89928 |
P7662 | Scilit journal ID | 1100280 |
P1156 | Scopus source ID | 26792 |
P495 | country of origin | United States of America | Q30 |
P1240 | Danish Bibliometric Research Indicator level | 1 | |
P8875 | indexed in bibliographic review | Science Citation Index Expanded | Q104047209 |
Scopus | Q371467 | ||
P407 | language of work or name | English | Q1860 |
P123 | publisher | Elsevier BV | Q746413 |
P1476 | title | Clinics in laboratory medicine |
Q101119154 | 2020: A Year for Clinical Microbiology |
Q90985776 | 25-Hydroxyvitamin D Testing: Immunoassays Versus Tandem Mass Spectrometry |
Q80116220 | A 21st century HPLC workflow for process R&D |
Q38571516 | A Laboratory Diagnostic Approach to Hepatobiliary Disease in Small Animals |
Q129438222 | A Nutrition Profile: Some Clinical Laboratory Considerations |
Q40480534 | A Practical Strategy for Diagnosis of Urinary Tract Infections |
Q39116106 | A Total Quality-Control Plan with Right-Sized Statistical Quality-Control |
Q51029315 | A buoyancy-driven compact thermocycler for rapid PCR. |
Q39463392 | A critical assessment of antipsychotic drug monitoring |
Q51917893 | A fully automated robotic system for high throughput fermentation. |
Q40196364 | A fundamental approach to the diagnosis of diseases of the thyroid gland. |
Q35122345 | A gene-targeted mouse model of P102L Gerstmann-Sträussler-Scheinker syndrome. |
Q41681902 | A longitudinal view of laboratory re-engineering in a community hospital group. |
Q30443386 | A low-cost, low-power consumption, miniature laser-induced fluorescence system for DNA detection on a microfluidic device |
Q41461087 | A molecular view of the neurologic porphyrias |
Q35122347 | A murine model of a familial prion disease. |
Q33812359 | A novel educational tool for teaching diagnostic reasoning and laboratory data interpretation to veterinary (and medical) students |
Q71438547 | A practical approach to the diagnosis of fungal infections of the respiratory tract |
Q52871675 | A quality control system and its application to clinical chemistry. |
Q36105187 | A review of prognostic pathologic features and algorithms for patients treated surgically for renal cell carcinoma |
Q39482738 | A strategic informatics approach to autoverification |
Q40817287 | A systems approach to assure optimal proficiency testing in the hematology laboratory |
Q70639091 | Abbreviation or elimination of the crossmatch |
Q90985800 | Accreditation and Quality Assurance for Clinical Liquid Chromatography-Mass Spectrometry Laboratories |
Q39116118 | Accreditation of Individualized Quality Control Plans by the College of American Pathologists |
Q53112932 | Accuracy controls: assessing trueness (bias). |
Q30439945 | Acetaminophen poisoning |
Q39500259 | Acquired immune deficiency syndrome (AIDS). |
Q45862730 | Acquired immunodeficiency syndrome (AIDS) in hemophilia. |
Q71704541 | Acquiring a laboratory computer system. Self evaluation and systems analysis |
Q37733298 | Acquiring a laboratory computer system. Understanding the issues. |
Q37733324 | Acquiring a laboratory computer system. Vendor selection and contracting |
Q71704536 | Acquiring a laboratory computer system. Vendor selection and contracting |
Q37872866 | Acral lentiginous melanoma |
Q41729732 | Actions for damages against medical examiners and the defense of sovereign immunity. |
Q58481800 | Acute Lymphoblastic Leukemia |
Q48604058 | Acute Myeloid Leukemia Immunophenotyping by Flow Cytometric Analysis |
Q40703548 | Acute care testing. Blood gases and electrolytes at the point of care. |
Q41136737 | Acute intermittent porphyria: laboratory diagnosis by molecular methods. |
Q72588224 | Acute iron poisoning in children |
Q34588059 | Acute leukemia |
Q73511106 | Acute lymphoblastic leukemia |
Q33685790 | Acute lymphoblastic leukemia. |
Q36894037 | Acute lymphoblastic leukemia: diagnosis and detection of minimal residual disease following therapy |
Q37961256 | Acute myeloid leukemia: conventional cytogenetics, FISH, and moleculocentric methodologies |
Q33854473 | Acute promyelocytic leukemia. From morphology to molecular lesions |
Q37773666 | Additional first-trimester ultrasound markers |
Q35780771 | Adipocyte biology and adipocytokines |
Q40350856 | Advanced Imaging Techniques for the Pathologist |
Q38127929 | Advanced techniques for detection and identification of microbial agents of gastroenteritis |
Q127408770 | Advances and Trends in Clinical Microbiology: The Next 20 Years |
Q97900036 | Advances in Clinical Laboratory Testing for Neurologic Disorders |
Q41605499 | Advances in basic concepts of autoimmune disease. |
Q30579772 | Advances in data exchange for the clinical laboratory. |
Q40935819 | Advances in endometrial pathology. |
Q74616643 | Advances in forensic toxicology |
Q68864710 | Advances in immunopathology |
Q34381273 | Advances in medical biological defense technology. |
Q35780736 | Advances in metanephrine testing for the diagnosis of pheochromocytoma |
Q34755539 | Advances in pretransfusion infectious disease testing: ensuring the safety of transfusion therapy |
Q60453022 | Advances on the Genetics of Mendelian Idiopathic Epilepsies |
Q34002446 | Adverse pregnancy outcomes after abnormal first-trimester screening for aneuploidy |
Q34381245 | Agroterrorism, biological crimes, and biowarfare targeting animal agriculture. The clinical, pathologic, diagnostic, and epidemiologic features of some important animal diseases |
Q68527280 | Alcohol |
Q41101438 | Alcohol and other chemicals in the development of hepatocellular carcinoma |
Q38039689 | Alcohol biomarkers |
Q38730450 | Alkaline phosphatases. Newer concepts in isoenzymes and clinical applications |
Q41461099 | Alpha thalassemia and its impact on other clinical conditions |
Q39590414 | Alpha-heavy chain disease |
Q40559576 | Alternate-site testing. Consider the analyst. |
Q78046177 | Alternative careers in the laboratory re-engineering paradigm |
Q38642899 | Alternatives to Serologic Testing for Diagnosis of Lyme Disease |
Q38730443 | Aminotransferases in disease |
Q38151559 | Amniotic fluid and advances in prenatal diagnosis |
Q41136691 | Amplification methods in the molecular diagnosis of genetic diseases. |
Q89488248 | An Overview of Direct-to-Consumer Testing |
Q88731166 | An Update Regarding the Molecular Genetics of Melanocytic Neoplasms and the Current Applications of Molecular Genetic Technologies in Their Diagnosis and Treatment |
Q39525584 | An algorithm for hematuria |
Q39637069 | An approach to practical problems in the diagnosis of lymphoproliferative disorders using cytochemistry and immunocytochemistry |
Q71438544 | An approach to the diagnosis of anaerobic pleuropulmonary infections |
Q80116210 | An automated metrics system to measure and improve the success of laboratory automation implementation |
Q41687622 | An overview and ranking of biochemical markers of cardiac disease. Strengths and limitations |
Q37773663 | An overview of first-trimester screening for chromosomal abnormalities |
Q40335920 | An overview of perinatal clinical pharmacology. |
Q38005545 | An update on arsenic |
Q37773662 | An update on cystic fibrosis screening |
Q34480105 | An update on the use of flow cytometry in HIV infection and AIDS. |
Q74313482 | Anabolic therapies |
Q54458444 | Anaerobic identification systems. |
Q38353354 | Analysis of bone marrow aspiration fluid using automated blood cell counters |
Q91021907 | Analysis of the Complement System in the Clinical Immunology Laboratory |
Q67928240 | Analysis of urinary sediment by transmission electron microscopy. An innovative approach to diagnosis and prognosis in renal disease |
Q40772941 | Analytic measurements of free thyroxine. |
Q33434236 | Analytical considerations for mass spectrometry profiling in serum biomarker discovery |
Q38075162 | Analytical performance specifications: relating laboratory performance to quality required for intended clinical use. |
Q30230516 | Anatomic laboratory and forensic aspects of biological threat agents |
Q86845377 | Anemia in pregnancy |
Q40335912 | Antenatal and neonatal bacterial infections: pathogenesis, significance, and diagnosis |
Q39639905 | Anti-idiotypes and autoimmune disease. |
Q37435536 | Anti-idiotypic-like antibodies detected following alloimmunization. Their characterization and relevance to allograft acceptance |
Q40103971 | Antiarrhythmic drug monitoring |
Q38214186 | Antibiotic resistance in nosocomial respiratory infections |
Q35792473 | Antibiotic resistance in the institutionalized elderly |
Q35792478 | Antibiotic-resistant gram-negative bacteria in hospitalized children |
Q35792468 | Antibiotic-resistant infections in the critically ill adult |
Q33484009 | Antibody-mediated perinatal diseases. |
Q85209439 | Anticoagulants |
Q36879113 | Anticoagulation in management of antiphospholipid antibody syndrome in pregnancy |
Q38108954 | Anticoagulation in pregnant patients with mechanical heart valves: clinical considerations |
Q37576580 | Anticoagulation monitoring |
Q38244369 | Anticoagulation strategies for the management of postoperative atrial fibrillation |
Q40265358 | Antiepileptic therapeutic drug monitoring. |
Q37628132 | Antigen-based assays for the identification of influenza virus and respiratory syncytial virus: why and how to use them in pediatric practice |
Q101119138 | Antimicrobial Stewardship: What the Clinical Laboratory Needs to Know |
Q69627340 | Antimicrobial susceptibility testing |
Q40751710 | Antimicrobial susceptibility testing and blood cultures. |
Q38500689 | Antimicrobial susceptibility testing of bacteria that cause gastroenteritis |
Q39669277 | Antimicrobial susceptibility tests and their role in therapeutic drug monitoring. |
Q40335946 | Antimicrobial therapeutic drug monitoring |
Q38642363 | Antimicrobic susceptibility testing. A personal perspective |
Q39669308 | Antineoplastic drug monitoring |
Q91021896 | Antineutrophil Cytoplasmic Antibodies Testing and Interpretation |
Q35227142 | Antineutrophil cytoplasmic autoantibodies |
Q91021888 | Antinuclear Antibody Tests |
Q34140585 | Antinuclear antibody testing |
Q41605537 | Antiphospholipid antibodies: standardization and testing |
Q33364410 | Antiphospholipid antibody syndrome. |
Q37576582 | Antiphospholipid syndrome review |
Q129448686 | Antiviral Chemotherapyand Prophylaxis of Viral Respiratory Disease |
Q30457345 | Antiviral chemotherapy and prophylaxis of viral respiratory disease |
Q38214193 | Antiviral resistance in influenza viruses: laboratory testing |
Q34876093 | Antivirals against HIV-1. |
Q40919224 | Apheresis. New opportunities. |
Q36655568 | Apolipoprotein A1 and B. |
Q38608998 | Apoprotein measurements and their clinical application |
Q68858979 | Application of gas chromatography/mass spectrometry instrument techniques to forensic urine drug testing |
Q37919288 | Application of immunohistochemistry in the differential diagnosis of skin tumors |
Q70506205 | Application of immunologic assays to the coagulation laboratory |
Q33434231 | Application of laser microdissection and reverse-phase protein microarrays to the molecular profiling of cancer signal pathway networks in the tissue microenvironment |
Q36105159 | Application of molecular diagnostic techniques to renal epithelial neoplasms |
Q35792507 | Application of pharmacokinetics and pharmacodynamics to antimicrobial therapy of respiratory tract infections. |
Q52712905 | Application of the predictive value model in the analysis of test effectiveness. |
Q47613814 | Applications of Mass Cytometry in Clinical Medicine: The Promise and Perils of Clinical CyTOF. |
Q39116131 | Applying Sigma Metrics to Reduce Outliers |
Q34381263 | Applying molecular biological techniques to detecting biological agents. |
Q49302092 | Approach to the analysis of body fluids for the detection of infection |
Q121009941 | Approaches to Deployment of Molecular Testing for SARS-CoV-2 in Resource-Limited Settings |
Q37787463 | Approaches to the Patient with Neurogenetic Disease |
Q34755554 | Appropriate use of clinical microbiology tests |
Q40165917 | Arachidonic Acid Metabolism and Macrophage Activation |
Q34588111 | Artifacts that may be present on a blood film |
Q30454434 | Aspects of aluminum toxicity |
Q37253661 | Aspiration cytology of breast |
Q38847012 | Aspirin for the Prevention of Preeclampsia and Intrauterine Growth Restriction |
Q80116229 | Assay optimization: a statistical design of experiments approach |
Q37836014 | Assay validation and diagnostic applications of major acute-phase protein testing in companion animals |
Q38160856 | Assays for complement activation. |
Q40148305 | Assessing hERG channel inhibition using PatchXpress |
Q36843101 | Assessing resident competency in laboratory medicine |
Q71120041 | Assessing the clinical utility of laboratory methods |
Q35815519 | Assessment of fetal lung maturity by laboratory methods |
Q40196383 | Assessment of hormonal disorders of water metabolism |
Q40891537 | Assessment of hyperphosphatemia and hypophosphatemia. |
Q40891532 | Assessment of hypocalcemia and hypercalcemia |
Q40819840 | Assessment of nutritional status. The clinician's perspective. |
Q33341841 | Assessment of platelet numbers and morphology in the peripheral blood smear |
Q40891567 | Assessment of renal function in the old. Special considerations. |
Q40891562 | Assessment of renal function in the young. Special considerations. |
Q40891577 | Assessment of renal function--glomerular and tubular |
Q38151557 | Assessment of tumor markers in cerebrospinal fluid |
Q35560079 | Atypical glandular cells |
Q35560077 | Atypical squamous cells: update on current concepts |
Q41605611 | Autoantibodies against oxidized LDL. A potential marker for atherosclerosis. |
Q41605598 | Autoantibodies and interstitial cystitis. |
Q33434234 | Autoantibody profiling for cancer detection |
Q41605508 | Autoantibody testing in patients with silicone implants. |
Q41605577 | Autoimmune diabetes. The role of autoantibody markers in the prediction and prevention of insulin-dependent diabetes mellitus. |
Q35171667 | Autoimmune disease as a cause of reproductive failure |
Q35999810 | Autoimmune diseases of the liver |
Q41605603 | Autoimmune inner ear disease--a real entity? |
Q68136817 | Autoimmune liver diseases |
Q73746514 | Autoimmune liver diseases |
Q38187980 | Autoimmune manifestations of human immunodeficiency virus (HIV) infection |
Q33413320 | Autoimmune phenomena in lymphoid malignancies. |
Q28262917 | Autoimmune polyglandular syndrome type 1 and the autoimmune regulator |
Q41605562 | Autoimmune reactivity in inflammatory bowel disease. |
Q72561683 | Autoimmune thyroid disease |
Q39639899 | Autoimmunity and otologic disease: clinical and experimental aspects |
Q40165923 | Autoimmunity in Immunopathology |
Q46690374 | Automated Analysis of Clinical Flow Cytometry Data: A Chronic Lymphocytic Leukemia Illustration |
Q39551536 | Automated and rapid methods in clinical microbiology: past, present and future |
Q38226218 | Automated antibiotic susceptibility testing: comparative evaluation of four commercial systems and present state |
Q72415366 | Automated blood culture systems |
Q57118465 | Automated forensic DNA purification optimized for FTA card punches and identifiler STR-based PCR analysis |
Q86716129 | Automated hematology analyzers: state of the art |
Q34588096 | Automated image processing. Past, present, and future of blood cell morphology identification |
Q80116233 | Automated solutions for total RNA isolation from diverse sample types |
Q71704532 | Automated systems in blood banking |
Q67928236 | Automated urinalysis |
Q53728401 | Automation and emerging technology in clinical microbiology. |
Q40603694 | Automation and quality control in the coagulation laboratory. |
Q67928242 | Automation and work-simplification in the urinalysis laboratory. A pilgrim's progress |
Q39551544 | Automation in blood banking and hemotherapy |
Q38127931 | Automation in the clinical microbiology laboratory |
Q39551531 | Automation of routine chemistry analysis. |
Q40772946 | Automation of thyroid function testing |
Q39639888 | Autoreactivity and altered immune responses in inflammatory bowel disease. |
Q85948313 | Avian Hematology |
Q30389855 | Avian influenza A H5N1 virus |
Q50059661 | B Lymphoblastic Leukemia Minimal Residual Disease Assessment by Flow Cytometric Analysis |
Q41161201 | BCL-2 gene rearrangements in lymphoid malignancies. |
Q40559542 | Background--setting the stage for alternate-site laboratory testing. |
Q38127933 | Bacterial strain typing |
Q38382997 | Bar Coding and Tracking in Pathology |
Q35957803 | Barriers to the implementation of patient safety initiatives |
Q39662391 | Basic principles of pharmacokinetics. |
Q40891493 | Basics of renal anatomy and physiology. |
Q38039691 | Bath salts |
Q41475783 | Bedside glucose testing. Applications in the home and hospital |
Q40817250 | Benign lymphocytosis and reactive neutrophilia. Laboratory features provide diagnostic clues. |
Q34914091 | Beyond identification: emerging and future uses for MALDI-TOF mass spectrometry in the clinical microbiology laboratory. |
Q44851437 | Beyond infectious disease: welcome to the era of population microbiology |
Q89488262 | Big Data Everywhere: The Impact of Data Disjunction in the Direct-to-Consumer Testing Model |
Q40335899 | Bilirubin measurements in neonates |
Q40819852 | Biochemical assessment of vitamins and trace metals |
Q34032509 | Biochemical markers of bone formation. |
Q40252074 | Biodynamic models as they relate to test selection |
Q95309632 | Bioinformatics in Clinical Genomic Sequencing |
Q39116151 | Biologic Variation Approach to Daily Laboratory |
Q91310614 | Biomarkers for Early Complications After Hematopoietic Stem Cell Transplantation |
Q38186263 | Biomarkers for cholesterol absorption and synthesis in hyperlipidemic patients: role for therapeutic selection |
Q91310593 | Biomarkers in Fetomaternal Tolerance |
Q91310617 | Biomarkers in Solid Organ Transplantation |
Q37984870 | Biomarkers quantification with antibody arrays in cancer early detection |
Q38847022 | Biophysical and Biochemical Screening for the Risk of Preterm Labor: An Update |
Q37773675 | Biophysical and biochemical screening for the risk of preterm labor |
Q34381249 | Bioregulators as instruments of terror |
Q36525329 | Bioregulators as prototypic nontraditional threat agents |
Q41159569 | Biosafety in the clinical mycobacteriology laboratory |
Q50140481 | Biospecimens and Biobanking in Global Health. |
Q38152765 | Biotin-labeled DNA probes for detection of Epstein-Barr virus by in-situ cytohybridization. |
Q101119148 | Blood Banking and Transfusion Medicine Challenges During the COVID-19 Pandemic |
Q33454886 | Blood bank regulations in India |
Q71120049 | Blood banking |
Q40265353 | Blood component therapy in neonatal medicine. |
Q70639108 | Blood components for hemotherapy |
Q40751718 | Blood cultures and immunocompromised patients. |
Q40751682 | Blood cultures. Introduction. |
Q34588034 | Blood film preparation and staining procedures |
Q40544853 | Blood protein defects associated with thrombosis. Laboratory assessment. |
Q42091580 | Blood transfusion in heart surgery. |
Q47960596 | Blue Nevi and Related Tumors |
Q37872874 | Blue nevi and related tumors |
Q38353366 | Body fluid cell counts by automated methods |
Q36243592 | Bone and connective tissue |
Q34032503 | Bone densitometry. |
Q33854493 | Bone marrow engraftment analysis after allogeneic bone marrow transplantation. |
Q77992806 | Bone marrow failure syndromes |
Q38642885 | Borrelia burgdorferi Pathogenesis and the Immune Response |
Q36325230 | Borrelia miyamotoi Disease: Neither Lyme Disease Nor Relapsing Fever |
Q50140491 | Breast Cancer in Low- and Middle-Income Countries: Why We Need Pathology Capability to Solve This Challenge. |
Q88731170 | Breast Carcinoma: Updates in Molecular Profiling 2018 |
Q38165307 | Breast carcinoma: molecular profiling and updates |
Q36322406 | Breast fine needle aspiration biopsy: prevailing recommendations and contemporary practices |
Q36433140 | Brown recluse spider envenomation |
Q48502304 | Building Cross-Country Networks for Laboratory Capacity and Improvement |
Q50140512 | Building Laboratory Capacity to Strengthen Health Systems: The Partners In Health Experience |
Q36599698 | Building a data base for monitoring and facilitating health care |
Q47566782 | Building the nation's first institute for laboratory quality |
Q34876135 | CD8+ T-cell immunity to HIV infection |
Q34032541 | Calcium and vitamin D. Diagnostics and therapeutics. |
Q64126218 | Campylobacter |
Q33767329 | Campylobacter jejuni. |
Q71388857 | Can physicians be rational about diagnostic tests? |
Q37984871 | Cancer biomarker detection by surface plasmon resonance biosensors. |
Q36571229 | Cancer markers of the 1990s. Comparison of the new generation of markers defined by monoclonal antibodies and oncogene probes to prototypic markers |
Q39273184 | Carbapenem-Resistant Enterobacteriaceae |
Q39669305 | Cardiac glycosides |
Q38186258 | Cardiac markers following cardiac surgery and percutaneous coronary intervention |
Q38186251 | Cardiac markers of myocardial necrosis: a history and discussion of milestones and emerging new trends |
Q87254206 | Cardiac markers. Preface |
Q38186255 | Cardiac troponins and high-sensitivity cardiac troponin assays |
Q38021114 | Cardiovascular disease in India |
Q33579184 | Cardiovascular proteomics: implications for clinical applications |
Q36243610 | Cardiovascular tissues for transplantation |
Q38108956 | Catastrophic antiphospholipid syndrome: diagnosis and management in pregnancy |
Q40751725 | Catheter-related infections and blood cultures |
Q34400299 | Cationic trypsinogen mutations and pancreatitis. |
Q81132213 | Cell and tissue banking |
Q38846978 | Cell-free DNA: Comparison of Technologies |
Q40165939 | Cellular and Humoral Defense Systems and Inflammatory Mechanisms in Thermal Injury |
Q34656668 | Cellular image analysis and imaging by flow cytometry |
Q40631511 | Cellular latency in HIV-1 infection. |
Q36238957 | Cellular proliferation markers in the evaluation of human cancer |
Q70169701 | Central nervous system tumors |
Q97900035 | Cerebrospinal Fluid Testing for Multiple Sclerosis |
Q38151553 | Cerebrospinal fluid cytopathology. |
Q35560097 | Cervical cytology automation: an update for 2003. The end of the quest nears? |
Q89488255 | Challenges with At-home and Mail-in Direct-to-Consumer Testing: Preanalytical Error, Reporting Results, and Result Interpretation |
Q38695509 | Chancroid and granuloma inguinale |
Q38053215 | Changing trends in laboratory testing in the United States: a personal, historical perspective |
Q36433135 | Chemically induced seizures |
Q37332946 | Chemokine-directed strategies to attenuate allograft rejection |
Q41687633 | Chest pain centers |
Q84332783 | Chikungunya |
Q39273197 | Chikungunya Virus. |
Q71033686 | Child abuse |
Q39669285 | Chloramphenicol and vancomycin |
Q36655580 | Cholesterol profile measurement by vertical auto profile method |
Q69962365 | Cholesterol screening |
Q38186259 | Cholesterol, lipoproteins, high-sensitivity c-reactive protein, and other risk factors for atherosclerosis |
Q35560087 | Choosing between competing technologies in the cytology laboratory |
Q39662421 | Chromatographic techniques for therapeutic drug monitoring |
Q38846996 | Chromosomal Microarrays for the Prenatal Detection of Microdeletions and Microduplications |
Q33854456 | Chromosomal abnormalities in acute leukemias. |
Q38020609 | Chromosomal abnormalities in myelodysplastic syndromes and acute myeloid leukemia. |
Q37961244 | Chromosomal structural rearrangements: detection and elucidation of mechanisms using cytogenomic technologies |
Q36239002 | Chronic granulomatous disease: diagnosis and classification at the molecular level. |
Q37961259 | Chronic myeloid leukemia: current perspectives |
Q34163928 | Classification and staging of melanoma. |
Q73805040 | Classification of diabetes mellitus |
Q93537650 | Classification, diagnosis, and molecular biology of lymphoproliferative disorders |
Q38020603 | Classifications of acute myeloid leukemia. |
Q36105163 | Clear cell renal cell carcinoma |
Q40393199 | Clinical Application of Reverse Transcription-Polymerase Chain Reaction for HIV Infection |
Q38571512 | Clinical Approach to Advanced Renal Function Testing in Dogs and Cats |
Q95309628 | Clinical Bioinformatics in Precise Diagnosis of Mitochondrial Disease |
Q127977761 | Clinical Decision Support: Tools, Strategies, and Emerging Technologies |
Q50059624 | Clinical Flow Cytometry: State-of-the-Art and New Approaches |
Q74818277 | Clinical HIV-1 virology |
Q88731146 | Clinical Implication of MicroRNAs in Molecular Pathology: An Update for 2018 |
Q38642888 | Clinical Manifestations and Treatment of Lyme Disease |
Q92427151 | Clinical Microbiology in Underresourced Settings |
Q101119127 | Clinical Pathogen Genomics |
Q43121172 | Clinical Screening and Genetic Testing |
Q30241317 | Clinical Toxicology and Its Relevance to Asthma and Atopy |
Q38924939 | Clinical Utility and Economic Impact of CYP2D6 Genotyping |
Q69689052 | Clinical and economic practice of quality control |
Q68858984 | Clinical and laboratory evaluation of patients exposed to neurotoxicants |
Q41461077 | Clinical and molecular aspects of multiple endocrine neoplasia. |
Q39467416 | Clinical and molecular parameters of HTLV-I infection |
Q36525316 | Clinical and pathologic differential diagnosis of selected potential bioterrorism agents of interest to pediatric health care providers |
Q40772955 | Clinical application of free thyroxine determinations. |
Q71649635 | Clinical applications of HLA typing |
Q34480088 | Clinical cytokine network cytometry |
Q52713142 | Clinical evaluation of test strategies. A decision analysis of parameter estimation. |
Q38186250 | Clinical features of heart failure and acute coronary syndromes |
Q34231434 | Clinical features of insulin resistance and beta cell dysfunction and the relationship to type 2 diabetes |
Q37332942 | Clinical impact of cytokine and growth factor genetic polymorphisms in thoracic organ transplantation |
Q38165298 | Clinical implication of microRNAs in molecular pathology |
Q37773668 | Clinical implications of first-trimester screening |
Q28253325 | Clinical importance of blood cultures |
Q36343255 | Clinical integration of next-generation sequencing technology |
Q39597086 | Clinical issues in the therapeutic monitoring of total parenteral nutrition |
Q36525308 | Clinical laboratories, the select agent program, and biological surety (biosurety). |
Q38021118 | Clinical laboratory accreditation in India |
Q44935195 | Clinical laboratory data are among the most detailed, objective, reliable, and useful measures of patient characteristics contained in the medical record |
Q39729729 | Clinical laboratory methods for the assessment and management of human allergic diseases |
Q41159633 | Clinical mycobacteriology. Activities and recommendations by the association of state and territorial public health laboratory directors. |
Q41159600 | Clinical mycobacteriology. Drug susceptibility testing |
Q40929171 | Clinical mycobacteriology. Work flow and optional protocols for laboratories in industrialized countries |
Q78046168 | Clinical perspectives on the modern laboratory |
Q37457342 | Clinical proteomic applications of formalin-fixed paraffin-embedded tissues |
Q74556482 | Clinical recognition and management of patients exposed to biological warfare agents |
Q37435530 | Clinical relevance of antibodies to non-HLA antigens in organ transplantation |
Q69885636 | Clinical significance of increased or decreased serum alkaline phosphatase isoenzymes |
Q68858975 | Clinical toxicology I |
Q68623777 | Clinical toxicology II. Strategies for clinical laboratory management: horizontal and vertical integration in hospital laboratories |
Q37942248 | Clinical toxicology of drugs used in the treatment of opiate dependency |
Q38021120 | Clinical trials and contract research organizations in India |
Q71676971 | Clinical use of B- and T-cell gene rearrangement analysis in hematopoietic disorders |
Q38244365 | Clinical use of the activated partial thromboplastin time and prothrombin time for screening: a review of the literature and current guidelines for testing |
Q39827230 | Clinical utility of body fluid analyses |
Q38353380 | Clinical utility of reticulocyte parameters |
Q37961249 | Clinical utility of single nucleotide polymorphism arrays |
Q34588041 | Clinical utility of the band count |
Q34480084 | Clinically relevant functional flow cytometry assays |
Q36525332 | Clinicopathologic aspects of animal and zoonotic diseases of bioterrorism |
Q34381239 | Clinicopathologic aspects of bacterial agents. |
Q34381222 | Clinicopathologic features of viral agents of potential use by bioterrorists |
Q30234604 | Clostridium difficile |
Q84332808 | Clostridium difficile |
Q39588090 | Coagulation and immunology |
Q41281326 | Coagulation for blood bankers |
Q73983767 | Coagulation point-of-care testing |
Q33490578 | Coagulopathies of liver disease. |
Q36433121 | Cocaine-induced chest pain |
Q48689696 | Coding, coverage, and compensation for pathology and laboratory medicine services |
Q40246654 | Collagen metabolites in the urine and serum of patients with cancer. |
Q40751728 | Collection, transport, and processing of blood cultures. |
Q39008409 | Common Interferences in Drug Testing |
Q69588694 | Common causes of false-positive CK-MB test for acute myocardial infarction |
Q35792489 | Community-acquired methicillin-resistant Staphylococcus aureus infections |
Q37836016 | Comparative hemostasis: animal models and new hemostasis tests |
Q91310609 | Complement and Transplantation: From New Mechanisms to Potential Biomarkers and Novel Treatment Strategies |
Q71704530 | Computer systems in clinical microbiology |
Q39751407 | Computer-assisted quality control: considerations for program design. |
Q69124739 | Computer-assisted therapeutic drug monitoring |
Q71614253 | Computer-based laboratory information systems |
Q41550567 | Computerized scanning devices for Pap smear screening: current status and critical review. |
Q70250073 | Computers in Anatomic Pathology |
Q37435629 | Conclusions: the maintenance of allograft acceptance. |
Q97900020 | Confounders in the Interpretation of Paraneoplastic and Neuronal Autoantibody Panels |
Q37872865 | Congenital melanocytic nevi |
Q37435559 | Considerations for monitoring cyclosporine in transplant recipients |
Q40559557 | Consolidating ancillary testing in multihospital systems |
Q35714651 | Constitutional and acquired autosomal aneuploidy |
Q40544848 | Contemporary laboratory monitoring of low molecular weight heparins. |
Q34480092 | Contributions of flow cytometry to the analysis of the myelodysplastic syndrome. |
Q39751412 | Controlling the cost of quality control. |
Q54478179 | Controversies in antimicrobial susceptibility testing. |
Q40215157 | Controversies in thyroid function testing |
Q36322413 | Core needle biopsy versus fine needle aspiration biopsy: are there similar sampling and diagnostic issues? |
Q101119129 | Coronavirus Detection in the Clinical Microbiology Laboratory: Are We Ready for Identifying and Diagnosing a Novel Virus? |
Q36603418 | Cost analysis and cost justification of automated data processing in the clinical laboratory. |
Q68623788 | Cost analysis in the toxicology laboratory |
Q33779501 | Cost benefit and outcomes analysis for fine-needle aspiration. Why do we know so little? |
Q33460478 | Cost containment and simplification in the blood bank |
Q44316038 | Cost containment in microbiology. |
Q93670797 | Cost containment in surgical pathology |
Q39865034 | Cost containment: strategies and responsibilities of the laboratory manager |
Q47612029 | Cost-Effective Flow Cytometry Testing Strategies |
Q38846989 | Cost-Effectiveness of Old and New Technologies for Aneuploidy Screening |
Q33779507 | Cost-based (Part A) pathology physician services. Origin, current spectrum, and future. |
Q41369697 | Cost-containment and the use of reference laboratories |
Q39850681 | Cost-effective use of laboratory tests: a joint responsibility of clinicians and laboratorians |
Q33779497 | Cost-effectiveness analysis in pathology |
Q37773670 | Cost-effectiveness of Down syndrome screening paradigms |
Q40246644 | Creatine kinase isoenzyme 1. |
Q39740931 | Creatine kinase isoenzymes |
Q78046144 | Creating integrated regional laboratory networks |
Q30439949 | Criminal poisoning: Munchausen by proxy |
Q36433150 | Criminal poisoning: medical murderers |
Q35957816 | Crossing the quality chasm: a requirement for successful cervical cancer prevention in developing countries |
Q37435524 | Crossmatch procedures used in organ transplantation |
Q67875366 | Cryptosporidiosis |
Q40480555 | Current Issues and Problems in Dealing with Anaerobes in the Clinical Laboratory |
Q40165931 | Current Status of Organ Transplantation |
Q37761790 | Current and future cellular transfusion products |
Q38165306 | Current applications of molecular genetic technologies to the diagnosis and treatment of cutaneous melanocytic neoplasms |
Q38151558 | Current assessment of microhematuria and leukocyturia. |
Q70615957 | Current concepts in reproductive toxicology |
Q35780752 | Current controversies in testosterone testing: aging and obesity |
Q36243597 | Current issues in pediatric stem cell transplantation |
Q34381268 | Current laboratory methods for biological threat agent identification |
Q38108952 | Current management of sickle cell disease in pregnancy. |
Q72673121 | Current status of alpha-fetoprotein testing |
Q38627672 | Cutaneous Malignant Vascular Neoplasms |
Q47571008 | Cutaneous Squamous Cell Carcinoma. |
Q40495352 | Cutaneous Sweat Gland Carcinomas with Basaloid Differentiation: An Update with Emphasis on Differential Diagnoses |
Q88761804 | Cutaneous T-cell Lymphoma |
Q39729751 | Cutaneous immunofluorescence |
Q114198432 | Cycle Threshold Values from Severe Acute Respiratory Syndrome Coronavirus-2 Reverse Transcription-Polymerase Chain Reaction Assays |
Q35029085 | Cyclospora cayetanesis |
Q39669323 | Cyclosporine controversies. |
Q35171705 | Cytogenetics and molecular cytogenetics in prenatal diagnosis |
Q40901919 | Cytogenetics. An evolving role in the diagnosis and treatment of cancer |
Q82700854 | Cytokine Networks in Transplant Rejection. Preface |
Q41605585 | Cytokines in autoimmune disease. |
Q37253675 | Cytologic diagnosis of leukemia and lymphoma. Values and limitations |
Q37253656 | Cytology of head and neck tumors, liver, and pancreas |
Q36322455 | Cytomorphology as a risk predictor: experience with fine needle aspiration biopsy, nipple fluid aspiration, and ductal lavage |
Q36322419 | Cytomorphology of benign breast disease. |
Q36322427 | Cytomorphology of common malignant tumors of the breast |
Q36322423 | Cytomorphology of fibrocystic change, high-risk proliferative breast disease, and premalignant breast lesions |
Q36322430 | Cytomorphology of rare malignant tumors of the breast |
Q50140486 | Cytopathology in Low Medical Infrastructure Countries: Why and How to Integrate to Capacitate Health Care |
Q37897857 | Cytopathology of sexually transmitted disease. |
Q41161218 | DNA analysis in the study of fungal infections in the immunocompromised host |
Q34480112 | DNA and cell cycle analysis as prognostic indicators in breast tumors revisited |
Q39829615 | DNA hybridization in the diagnosis of bacterial diarrhea |
Q38642408 | DNA probes for antimicrobial susceptibility testing |
Q31142730 | Data mining and infection control |
Q31142734 | Data mining for biomarker development: a review of tissue specificity analysis |
Q30440132 | Data mining in genomics |
Q47956102 | Death caused by fire |
Q41729702 | Death in custody |
Q71033692 | Death or injury caused by electrocution |
Q71033679 | Death or injury caused by explosion |
Q72369414 | Decentralized testing in the 1990s. A survey of United States hospitals |
Q91619881 | Decision Support Tools within the Electronic Health Record |
Q91619896 | Decision Support and Patient Safety |
Q91619931 | Decision Support from a Reference Laboratory Perspective |
Q91619916 | Decision Support in Transfusion Medicine and Blood Banking |
Q91619908 | Decision Support to Enhance Automated Laboratory Testing by Leveraging Analytical Capabilities |
Q37733335 | Decision-oriented test request forms. A system for implementing practice parameters in laboratory medicine |
Q37067261 | Dendritic cells and chemokine-directed migration in transplantation: where are we headed? |
Q34118200 | Dengue virus |
Q84056096 | Dermatopathology. Preface |
Q37733347 | Design of a clinical laboratory computer system |
Q84056107 | Desmoplastic melanoma |
Q35957821 | Detecting and preventing the occurrence of errors in the practices of laboratory medicine and anatomic pathology: 15 years' experience with the College of American Pathologists' Q-PROBES and Q-TRACKS programs |
Q41461060 | Detection of Mycobacterium tuberculosis by molecular methods. |
Q39669318 | Detection of androgenic anabolic steroids in urine |
Q35623159 | Detection of antiretroviral resistance in HIV-1. |
Q40335907 | Detection of free bilirubin and estimation of reserve albumin binding capacity |
Q33281430 | Determination of cell colony formation in a high-content screening assay |
Q74616645 | Developing medicolegal death investigator systems in forensic pathology |
Q38075158 | Developing risk-based quality control plans: an overview of CLSI EP23-A. |
Q37288639 | Development and validation of a protein-based signature for the detection of ovarian cancer |
Q90985813 | Development of a 25-Hydroxyvitamin D Liquid Chromatography-Tandem Mass Spectrometry Assay, Cleared by the Food and Drug Administration, via the De Novo Pathway |
Q37457347 | Development of high-throughput mass spectrometry-based approaches for cancer biomarker discovery and implementation. |
Q38353347 | Development, history, and future of automated cell counters |
Q37628130 | Developments in immunologic assays for respiratory viruses |
Q37628128 | Developments in tissue culture detection of respiratory viruses |
Q46138275 | Diabetes, hematology/coagulation in pregnancy |
Q73805043 | Diabetic nephropathy |
Q35780731 | Diagnosis and management of medullary thyroid carcinoma |
Q33407932 | Diagnosis and management of neonatal alloimmune thrombocytopenia in pregnancy |
Q69467063 | Diagnosis and treatment of viral infections |
Q38571530 | Diagnosis of Disorders of Iron Metabolism in Dogs and Cats |
Q49641900 | Diagnosis of Plasma Cell Dyscrasias and Monitoring of Minimal Residual Disease by Multiparametric Flow Cytometry |
Q38571520 | Diagnosis of Small Intestinal Disorders in Dogs and Cats |
Q40891595 | Diagnosis of acute and chronic renal failure |
Q33685798 | Diagnosis of childhood acute myeloid leukemia. |
Q33948266 | Diagnosis of human papillomavirus gynecologic infections |
Q67875362 | Diagnosis of important parasitic diseases. Laboratory management: payment for hospital-based pathologist services |
Q35999806 | Diagnosis of minimal residual disease in bone marrow transplant patients |
Q35029080 | Diagnosis of nontuberculous mycobacterial infections |
Q70401610 | Diagnosis of pheochromocytoma |
Q35122332 | Diagnosis of prion diseases |
Q68211080 | Diagnosis of viral hepatitis |
Q71438553 | Diagnosis of viral respiratory infections in the 1980s |
Q38020604 | Diagnosis, classification, and course of myelodysplastic syndromes. |
Q71649630 | Diagnosis, prevention, and therapy in hemolytic disease of the newborn |
Q56764015 | Diagnostic Cytology in Veterinary Medicine: A Comparative and Evidence-Based Approach |
Q54206407 | Diagnostic Molecular Microbiology: A 2018 Snapshot. |
Q91021903 | Diagnostic Pitfalls in Immunology Testing |
Q97900032 | Diagnostic Testing for Patients with Spinal Muscular Atrophy |
Q97900016 | Diagnostic and Prognostic Laboratory Testing for Alzheimer Disease |
Q34914108 | Diagnostic assays for identification of microorganisms and antimicrobial resistance determinants directly from positive blood culture broth |
Q39507903 | Diagnostic electron microscopy of male genital tract tumors |
Q68942780 | Diagnostic electron microscopy of tumors |
Q38209806 | Diagnostic enzymes for pancreatic disease |
Q69393042 | Diagnostic enzymology |
Q33779495 | Diagnostic errors in surgical pathology |
Q83373126 | Diagnostic hematology of reptiles |
Q37961250 | Diagnostic implications of excessive homozygosity detected by SNP-based microarrays: consanguinity, uniparental disomy, and recessive single-gene mutations |
Q38165299 | Diagnostic molecular microbiology: a 2013 snapshot |
Q40947284 | Diagnostic molecular pathology in the twenty-first century. |
Q38730433 | Diagnostic use of CK-MM and CK-MB isoforms for detecting myocardial infarction. |
Q35999801 | Diagnostic use of molecular probes before and after marrow transplantation |
Q34480098 | Diagnostic utility of red cell flow cytometric analysis. |
Q68211078 | Diagnostic virology |
Q129309176 | Diagnostics Stewardship in Molecular Microbiology: From at-home Testing to Next-Generation Sequencing |
Q50150572 | Diesel exhaust in the occupational setting. Current understanding of pulmonary health effects. |
Q38730430 | Differential diagnosis of patients with abnormal serum creatine kinase isoenzymes. |
Q36433113 | Differentiating the causes of metabolic acidosis in the poisoned patient |
Q39637035 | Differentiation of human T cells |
Q38353370 | Digital image analysis of blood cells |
Q39450257 | Digital image processing for microscopy |
Q39450252 | Digital imaging as a teaching tool for pathologists |
Q38053211 | Digital imaging in pathology. |
Q39450261 | Digital imaging standards and system interoperability |
Q40265363 | Digitalis and vasoactive drugs. |
Q40187105 | Direct and indirect chemical exposure in children. |
Q92427181 | Direct-from-Specimen Pathogen Identification: Evolution of Syndromic Panels |
Q89488280 | Direct-to-Consumer Testing: The Role of Laboratory Medicine Physicians and Scientists |
Q89488252 | Direct-to-Consumer Tests on the Market Today: Identifying Valuable Tests from Those with Limited Utility |
Q40139191 | Disorders of Stimulus-Response Coupling in Neutrophils |
Q40335930 | Disorders of carbohydrate metabolism |
Q40196377 | Disorders of gonadal function |
Q40335925 | Disorders of the endocrine system. |
Q40603699 | Disseminated intravascular coagulation. Objective laboratory diagnostic criteria and guidelines for management |
Q38021119 | Distant testing in laboratory hematology and flow cytometry--the Indian experience |
Q92427175 | Distributed Microbiology Testing: Bringing Infectious Disease Diagnostics to Point of Care |
Q93013152 | Diversity of Killer Cell Immunoglobulin-Like Receptors and Disease |
Q39751419 | Documentation of safe work practices in the clinical laboratory. |
Q35178891 | Donor Screening |
Q91310611 | Donor-Specific HLA Antibodies as Biomarkers of Transplant Rejection |
Q37435514 | Donor-specific antibodies. Clinical relevance of antibodies detected in lymphocyte crossmatches. |
Q38021115 | Down syndrome in India--diagnosis, screening, and prenatal diagnosis |
Q129480418 | Drug Interference with the Assessment of Nutritional Status |
Q88760974 | Drug Testing and Toxicology: Redefining the Plague of Darkness |
Q39008462 | Drug Toxicities of Common Analgesic Medications in the Emergency Department |
Q38039690 | Drug abuse: newly-emerging drugs and trends |
Q39662431 | Drug screening in hospital clinical laboratories |
Q39662436 | Drug screening in the workplace |
Q77802898 | Drug testing as part of the war on drugs |
Q38039695 | Drug testing in the neonate |
Q37617662 | Drug-of-abuse testing at the point of care |
Q51988105 | Drugs of abuse testing in a psychiatric outpatient service. |
Q38005548 | Drugs-of-abuse testing. Screening and confirmation |
Q69544188 | Dry chemistry: its expanded role in doctor's office testing |
Q37342105 | Dynamic pharmacogenetic models in anticoagulation therapy |
Q40192032 | Dysfibrinogenemia. A current perspective |
Q129440822 | Dysfibrinogenemsa: A Current Perspective |
Q34163893 | Dysplastic melanocytic nevi and prognostically indeterminate nevomelanomatoid proliferations |
Q37872863 | Dysplastic nevi |
Q81481271 | Early events in acute pancreatitis |
Q30148694 | Ebola Virus Disease: An Update on Epidemiology, Symptoms, Laboratory Findings, Diagnostic Issues, and Infection Prevention and Control Issues for Laboratory Professionals |
Q34118205 | Ebola and marburg hemorrhagic fever |
Q38642882 | Ecology and Epidemiology of Lyme Borreliosis |
Q71614256 | Economic analysis in assessing technology in clinical laboratories |
Q40544865 | Economic tools for the pathologist. |
Q40079490 | Ectopic Hormones as Tumor Markers |
Q36843143 | Education of the PhD in laboratory medicine |
Q35560094 | Effusion cytology in ovarian cancer: new molecular methods as aids to diagnosis and prognosis |
Q37253672 | Effusion cytology. |
Q39827235 | Electron microscopy of body fluids. |
Q36484442 | Electron microscopy of leukemias and lymphomas |
Q77316041 | Electronic imaging in cytopathology |
Q69588688 | Electrophoresis of human alkaline and acid phosphatases |
Q69588685 | Electrophoresis of serum proteins and isoenzymes |
Q39740933 | Electrophoretic assays of amylase isoenzymes and isoforms |
Q39740923 | Electrophoretic techniques in today's clinical laboratory |
Q37007601 | Elements of Payment for Hospital-Based Pathologist Services |
Q34480059 | Eleven-color flow cytometry. A powerful tool for elucidation of the complex immune system. |
Q30342746 | Emerging fungal diseases: the importance of the host. |
Q35869011 | Emerging fungal resistance |
Q35868996 | Emerging gram-negative enteric infections |
Q35868992 | Emerging gram-positive bacterial infections |
Q35869028 | Emerging infections in animals--potential new zoonoses? |
Q35869024 | Emerging infections in transfusion medicine |
Q35869001 | Emerging intracellular bacterial infections |
Q37628138 | Emerging molecular assays for detection and characterization of respiratory viruses |
Q36525304 | Emerging natural threats and the deliberate use of biological agents |
Q35869015 | Emerging parasitic infections |
Q50576217 | Emerging pathogens in transfusion medicine. |
Q38214194 | Emerging respiratory viruses other than influenza |
Q80483273 | Emerging viral infections |
Q40130487 | Endocrine Assays in the Monitoring of Pregnancy |
Q35780781 | Endocrine autoantibodies |
Q40165894 | Endothelial Cells and Inflammation |
Q38730448 | Enhanced cardiac enzyme profile |
Q95309606 | Enhancing Diagnosis Through RNA Sequencing |
Q38724927 | Enhancing and Customizing Laboratory Information Systems to Improve/Enhance Pathologist Workflow |
Q91619951 | Enhancing the Value of the Laboratory with Clinical Decision Support |
Q33767366 | Enterically transmitted hepatitis. Hepatitis A and E viruses. |
Q41136722 | Enzymatic and molecular diagnosis of Gaucher disease |
Q41605518 | Enzyme immunoassays for antinuclear antibodies |
Q40088462 | Enzyme tests in cancer |
Q38209807 | Enzymes in cancer |
Q38308659 | Enzymes in sarcoidosis. Angiotensin-converting-enzyme (ACE). |
Q38192751 | Eosinophiluria |
Q41729706 | Epidemiologic aspects of forensic pathology |
Q35171716 | Epidemiologic monitoring of prenatal screening for neural tube defects and Down syndrome |
Q34032492 | Epidemiology of fractures and assessment of fracture risk |
Q40935831 | Epithelial neoplasms of the ovary. An update on current concepts. |
Q39199688 | Epstein-Barr virus--associated lymphoproliferative lesions |
Q41281398 | Error detection and reduction in blood banking. |
Q30344327 | Error-free pathology: applying lean production methods to anatomic pathology. |
Q40255075 | Erythrocyte agglutination. Red cell membrane topography and the role of interfacial tension. |
Q33767334 | Escherichia coli. EAEC, EHEC, EIEC, ETEC. |
Q39662456 | Establishing a therapeutic drug monitoring consultation service |
Q41101411 | Ethanol and hepatocellular injury. |
Q54520329 | Ethanol. |
Q41136753 | Ethical issues in screening and testing for genetic diseases. |
Q39790812 | Evaluating doctors' office testing patterns |
Q40187118 | Evaluating exposures to plants |
Q33948276 | Evaluation of abnormal cervical cytology. |
Q74079835 | Evaluation of cardiac STATus CK-MB/myoglobin device for rapidly ruling out acute myocardial infarction |
Q52723969 | Evaluation of colloids, crystalloids, whole blood, and red cell therapy in the critically ill patient. |
Q40891573 | Evaluation of elevated blood pressure. |
Q71098434 | Evaluation of laboratory instrumentation |
Q40891517 | Evaluation of renal concentrating and diluting ability. |
Q85948320 | Evaluation of the Blood Film |
Q35178888 | Evolution in Indications for Blood Component Transfusion |
Q35792512 | Evolution of amoxicillin/clavulanate in the treatment of adults with acute bacterial rhinosinusitis and community-acquired pneumonia in response to antimicrobial-resistance patterns |
Q30332329 | Evolving microbes and re-emerging streptococcal disease. |
Q40335892 | Exchange transfusion |
Q30473042 | Experimental aluminum encephalomyelopathy. Relationship to human neurodegenerative disease. |
Q37733310 | Expert systems and the clinical laboratory information system |
Q38924951 | Extracellular Vesicles Move Toward Use in Clinical Laboratories |
Q44951209 | Fecal occult blood testing |
Q40772983 | Federal regulation of clinical laboratories and the Clinical Laboratory Improvement Amendments of 1988--Part I. |
Q40817295 | Federal regulation of clinical laboratories and the Clinical Laboratory Improvement Amendments of 1988--Part II. |
Q101119140 | Fellowship Training for the Future Clinical Microbiology Laboratory Director |
Q36243606 | Fertility: tissue and cell banking overview |
Q70670722 | Fibrinopeptide A in the diagnosis and treatment of deep venous thrombosis and pulmonary embolism |
Q51808935 | Fibrohistiocytic Tumors. |
Q40819895 | Financial implications of malnutrition. |
Q77316026 | Fine needle aspiration biopsy of the liver. Principal diagnostic challenges |
Q77316016 | Fine needle aspiration biopsy of the pancreas |
Q77316013 | Fine needle aspiration cytology of papillary neoplasms |
Q77316019 | Fine needle aspiration cytology of the kidney, renal pelvis, and adrenal |
Q77316023 | Fine needle aspiration cytology of the thyroid |
Q77316036 | Fine needle aspiration cytopathology of malignant lymphoma |
Q77316032 | Fine needle aspiration of soft-tissue lesions |
Q40480539 | Fine-Needle Aspiration and Surgical Pathology of Infectious Lesions: Morphologic Features and the Role of the Clinical Microbiology Laboratory for Rapid Diagnosis |
Q40935869 | Fine-needle aspiration cytology of the ovary |
Q72561687 | Fine-needle aspiration cytology of the thyroid. A 12-year experience with 11,000 biopsies |
Q37773678 | First- and second-trimester screening for preeclampsia and intrauterine growth restriction |
Q38847016 | First-, Second-, and Third-Trimester Screening for Preeclampsia and Intrauterine Growth Restriction |
Q37773664 | First-trimester genetic counseling: perspectives and considerations |
Q37773665 | First-trimester screening for chromosomal abnormalities: advantages of an instant results approach |
Q85948318 | Fish Hematology and Associated Disorders |
Q40817230 | Fitting the cell counter to the bed count. |
Q33767357 | Flagellates and ciliates |
Q50059657 | Flow Cytometric Assessment of Chronic Myeloid Neoplasms. |
Q50059638 | Flow Cytometric Evaluation of Primary Immunodeficiencies |
Q91021911 | Flow Cytometry as a Diagnostic Tool in Primary and Secondary Immune Deficiencies |
Q50059643 | Flow Cytometry in Pediatric Hematopoietic Malignancies |
Q50059675 | Flow Cytometry of B-Cell Neoplasms |
Q50059670 | Flow Cytometry of T cells and T-cell Neoplasms. |
Q36894032 | Flow cytometric assessment of T-cell chronic lymphoproliferative disorders |
Q36894027 | Flow cytometric evaluation of B-cell lymphoid neoplasms |
Q38151561 | Flow cytometry in body fluid analysis. |
Q39525571 | Flow cytometry of urine |
Q40817234 | Flow cytometry. From research to clinical laboratory applications |
Q39669287 | Flucytosine (5-fluorocytosine). |
Q82686454 | Fluorescence in situ hybridization |
Q91021919 | Food Allergy Testing |
Q101119144 | Food Safety Genomics and Connections to One Health and the Clinical Microbiology Laboratory |
Q41161254 | Forensic DNA tests |
Q39008456 | Forensic Toxicology: An Introduction |
Q71033711 | Forensic aspects of ethyl alcohol |
Q41729718 | Forensic pathology of heat-and cold-related injuries. |
Q74616640 | Forensic pathology. Pulmonary disease |
Q40865043 | Forensic science. An overview of new technology and instrumentation for the forensic pathologist |
Q38244374 | Four-factor prothrombin complex concentrate versus plasma for urgent vitamin K antagonist reversal: new evidence |
Q39662397 | Free drug monitoring. |
Q33779536 | French gynecologic cytology |
Q50140474 | From Access to Collaboration: Four African Pathologists Profile Their Use of the Internet and Social Media |
Q36062653 | From colonic polyps to colon cancer: pathophysiology, clinical presentation, and diagnosis |
Q50576229 | From stem cell to red blood cells in vitro: "the 12 labors of Hercules". |
Q38924921 | Fundamentals of Pharmacogenetics in Personalized, Precision Medicine |
Q40891500 | Fundamentals of clinical acid-base evaluation |
Q37342094 | Fundamentals of pharmacology and applications in pharmacogenetics |
Q36525322 | Fungi as bioweapons |
Q37761789 | Future of molecular testing for red blood cell antigens |
Q81471257 | Future trends |
Q38405854 | Future-generation sequencing and clinical microbiology. |
Q129469863 | GC/MS Analysis of m -Hydroxybenzoylecgonine in Urine: Forensic Implication in Cocaine Use |
Q42536726 | GC/MS analysis of m-hydroxybenzoylecgonine in urine. Forensic implication in cocaine use. |
Q37253668 | Gastrointestinal cytology. |
Q33854489 | Gene therapy of pediatric leukemia. |
Q41161258 | Gene therapy: a brief review |
Q40751731 | General principles in the laboratory detection of bacteremia and fungemia. |
Q38847000 | Genetic Carrier Screening in the Twenty-first Century |
Q38846985 | Genetic Counseling for Patients Considering Screening and Diagnosis for Chromosomal Abnormalities |
Q91310588 | Genetic Polymorphism in Cytokines and Costimulatory Molecules in Stem Cell and Solid Organ Transplantation |
Q97900013 | Genetic Testing for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia: Impact on Clinical Management |
Q40937839 | Genetic heterogeneity of hepatitis C virus. The clinical significance of genotypes and quasispecies behavior |
Q50576237 | Genetically engineered pigs as a source for clinical red blood cell transfusion. |
Q37787469 | Genetics of Personality Disorders |
Q85014871 | Genetics of Psychiatric Disorders Methods: Molecular Approaches |
Q55548230 | Genetics of addictions. |
Q37961255 | Genetics of chronic lymphocytic leukemia |
Q41136743 | Genetics of colorectal and breast cancer. |
Q81481278 | Genetics of hereditary pancreatic carcinoma |
Q37897832 | Genital Chlamydia infections |
Q38290970 | Genital herpes infections |
Q64129486 | Genital human papillomavirus infections |
Q38695499 | Genital mycoplasma infections. |
Q37253664 | Genitourinary cytology |
Q40104850 | Germ Cell Tumors and Biochemical Markers in Clinical and Experimental Research |
Q93952278 | Gestational diabetes mellitus |
Q40935850 | Gestational trophoblastic disease. New approaches to diagnosis |
Q50140480 | Global Health Pathology Research: Purpose and Funding |
Q50140464 | Global Health and Pathology |
Q37576590 | Global hemostasis testing thromboelastography: old technology, new applications |
Q83373117 | Glucose monitoring in diabetic dogs and cats: adapting new technology for home and hospital care |
Q34231439 | Glycated proteins in diabetes |
Q71628123 | Glycoproteins as tumor markers |
Q30457701 | Gold nanoparticle-mediated detection of circulating cancer cells |
Q69235264 | Gonorrhea |
Q60117226 | Governance in the European Union: The European Blood Directive as an Evolving Practice |
Q38020627 | Granulocytic sarcoma |
Q38108953 | Guidelines for use of anticoagulation in pregnancy |
Q88731174 | Gynecologic Cancers: Molecular Updates 2018 |
Q36414491 | Gynecologic Cytology: Practical Considerations and Limitations |
Q38165309 | Gynecologic cancers: molecular updates |
Q38021110 | HIV testing in India |
Q30381775 | HIV testing near the patient: changing the face of HIV testing. |
Q40393212 | HIV-1 Drug Resistance: Molecular Pathogenesis and Laboratory Monitoring |
Q34875958 | HIV-1 RNA and viral load |
Q40631515 | HIV-1 antibodies and serology. |
Q40631528 | HIV-1 burden as a marker of disease progression and clinical response to therapy in AIDS. |
Q34876042 | HIV-1 entry and entry inhibitors as therapeutic agents |
Q34876000 | HIV-1 genotypic and phenotypic resistance |
Q34875979 | HIV-1 replication cycle |
Q34876018 | HIV-1 reservoirs |
Q34876150 | HIV-1 vaccines: the search continues |
Q40631503 | HIV-induced T-lymphocyte depletion |
Q93013238 | HLA in Transplantation and Beyond |
Q39199682 | HTLV-II and human lymphoproliferative disorders. |
Q39637059 | Hairy-cell leukemia. Morphologic, cytochemical, and immunologic features |
Q36105185 | Handling and reporting of tumor-containing kidney specimens |
Q33894549 | Hantaviruses |
Q51029345 | Hardware flexibility of laboratory automation systems: analysis and new flexible automation architectures. |
Q90985796 | Harmonization of Liquid Chromatography-Tandem Mass Spectrometry Protein Assays |
Q38724954 | Health Information Systems. |
Q89488245 | Health Literacy and the Desire to Manage One's Own Health |
Q37733319 | Health care information systems. Patient-centered integration is the key. |
Q34505931 | Heavy metal poisoning: clinical presentations and pathophysiology. |
Q33767362 | Helminthic food-borne infections |
Q54043670 | Helping physicians use laboratory tests. |
Q33361396 | Hemapheresis in pregnancy |
Q51741421 | Hematologic Assessment in Pet Rats, Mice, Hamsters, and Gerbils: Blood Sample Collection and Blood Cell Identification. |
Q33685757 | Hematologic values and appearances in the healthy fetus, neonate, and child |
Q53791225 | Hematological Assessment in Pet Guinea Pigs (Cavia porcellus): Blood Sample Collection and Blood Cell Identification. |
Q85948306 | Hematological Assessment in Pet Rabbits: Blood Sample Collection and Blood Cell Identification |
Q39551540 | Hematology analyzers |
Q38353385 | Hematology analyzers: special considerations for pediatric patients |
Q50993230 | Hematology of the Domestic Ferret (Mustela putorius furo). |
Q69544193 | Hematology testing in the doctor's office laboratory |
Q38353396 | Hematology testing in urgent care and resource-poor settings: an overview of point of care and satellite testing |
Q71120038 | Hematology: automated white blood cell differential counting flow-analysis |
Q38021116 | Hemoglobinopathies in India--clinical and laboratory aspects. |
Q33685775 | Hemolytic anemia in children. |
Q84374169 | Hemostasis and coagulation |
Q41422597 | Hepatic Injury Due to Environmental Agents |
Q71498805 | Hepatic fibrogenesis |
Q41101422 | Hepatic regeneration. The role of regeneration in pathogenesis of chronic liver diseases. |
Q71498810 | Hepatitis B and C viruses and hepatocellular carcinoma |
Q41101458 | Hepatitis delta virus. Genetics and pathogenesis. |
Q40937845 | Hepatocellular injury in hepatitis B and C virus infections. |
Q36433145 | Hepatotoxicity associated with herbal products |
Q35122319 | Hereditary Creutzfeldt-Jakob disease and fatal familial insomnia. |
Q35122324 | Hereditary prion protein amyloidoses |
Q37930050 | High throughput automated LC-MS/MS analysis of endogenous small molecule biomarkers |
Q53407106 | High-flow multiplexed MRM-based analysis of proteins in human plasma without depletion or enrichment. |
Q53473183 | History of the development and use of biological weapons. |
Q34413461 | History of the development of the classification of renal cell neoplasia |
Q39736415 | Home monitoring of diabetes mellitus--a quiet revolution |
Q80180385 | Homocysteine |
Q34245948 | Horizontal and vertical integration in hospital laboratories and the laboratory information system |
Q69978295 | Hospital laboratory inventory management |
Q81471242 | Hospital laboratory outreach: benefits and planning |
Q38021107 | Host responses in malaria disease evaluated through nuclear magnetic resonance-based metabonomics |
Q47613841 | How Do We Use Multicolor Flow Cytometry to Detect Minimal Residual Disease in Acute Myeloid Leukemia? |
Q93013179 | Human Leukocyte Antigen Associations in Drug Hypersensitivity Reactions |
Q93013089 | Human Leukocyte Antigen Epitope Matching in Solid Organ Transplantation |
Q93013064 | Human Leukocyte Antigen Typing by Next-Generation Sequencing |
Q93013214 | Human Leukocyte Antigen and Disease Associations: A Broader Perspective |
Q35171663 | Human chorionic gonadotropin testing for early pregnancy viability and complications |
Q33899174 | Human ehrlichiosis and anaplasmosis |
Q38005546 | Human growth hormone. Its use and abuse |
Q35029074 | Human herpesvirus 8, Kaposi's sarcoma, and associated conditions |
Q84332772 | Human metapneumovirus |
Q39729740 | Human oncogene-related proteins in urine during pregnancy and neoplasia |
Q33948260 | Human papillomavirus in cervical neoplasia. Role, risk factors, and implications. |
Q33948288 | Human papillomavirus oncogenesis |
Q33948254 | Human papillomavirus. Epidemiology, transmission, and pathogenesis. |
Q73916627 | Human papillomavirus. Introduction |
Q36243614 | Human skin banking |
Q34755474 | Hypercoagulability test strategies in the protein C and protein S pathway |
Q40079477 | Hypercortisolism |
Q36433130 | Hyperthermic syndromes induced by toxins. |
Q34231443 | Hypoglycemic disorders. |
Q34032548 | IGF-I and osteoporosis |
Q35957827 | Identification errors in pathology and laboratory medicine |
Q40929176 | Identification of mycobacteria by conventional methods. |
Q40842659 | If cells could talk. The application of new techniques to cytopathology |
Q38474493 | Image output technology. |
Q39463610 | Image processing in forensic pathology |
Q36322409 | Image-directed fine needle aspiration biopsy in nonpalpable breast lesions |
Q39450237 | Imaging input technology. |
Q38182229 | Immune modulators as antiviral agents |
Q34876070 | Immune reconstitution |
Q39662425 | Immunoassays in therapeutic drug monitoring. |
Q39467411 | Immunobiology of malignant B cells and immunoregulatory cells in B-chronic lymphocytic leukemia. |
Q37007595 | Immunodiagnosis of Schistosomiasis: Screen with FAST-ELISA and Confirm with immunoblot |
Q37435491 | Immunogenetics of the human major histocompatibility complex |
Q39637082 | Immunoglobulin gene rearrangement and its implications for the study of B-cell neoplasia |
Q129482971 | Immunohfstochemistry in Surgical Pathology: The Case of the Undifferentiated Malignant Neoplasm |
Q40935874 | Immunohistochemical approaches to diagnosis in gynecologic pathology. |
Q37919283 | Immunohistochemical diagnosis of nervous system neoplasms |
Q37919294 | Immunohistochemistry in surgical pathology. The case of the undifferentiated malignant neoplasm |
Q91310604 | Immunologic Effects of the Microbiota in Organ Transplantation |
Q91021927 | Immunologic Risk Assessment and Approach to Immunosuppression Regimen in Kidney Transplantation |
Q36525341 | Immunologic aspects of select agents |
Q38695490 | Immunologic evaluation of persons infected with human immunodeficiency virus |
Q37435624 | Immunologic heterogeneity among potential transplant recipients. Prospects for predicting immune responses to allografts with in vitro tests |
Q70497529 | Immunologic techniques utilized in the diagnosis of occupational lung disease |
Q40335878 | Immunology: current and future technology assessment. |
Q34231413 | Immunopathology of immune-mediated (type 1) diabetes |
Q39729745 | Immunopathology of renal disease |
Q34480077 | Immunophenotypic analysis with enhanced sensitivity of detection by enzymatic amplification staining. |
Q39637053 | Immunophenotyping in the diagnosis and classification of acute lymphoblastic leukemia |
Q38020607 | Immunophenotyping of acute myeloid leukemia cells. |
Q35178922 | Immunosuppressive Effects of Blood Transfusion |
Q38108950 | Impact of diabetes on aneuploidy screening |
Q70250085 | Implementing an Information System |
Q30388207 | Implementing information systems |
Q33779520 | Implications of prognostic markers in brain tumors. |
Q40891557 | Important aspects concerning evaluation of renal function and blood pressure. Kinins, prostaglandins, lead |
Q35957796 | Improving patient safety by examining pathology errors |
Q40919218 | Improving the safety of transfusion therapy |
Q33948271 | In situ diagnosis of human papillomaviruses. |
Q36571243 | In situ hybridization |
Q40631538 | In situ polymerase chain reaction and HIV-1. |
Q35122360 | In vitro conversion of normal prion protein into pathologic isoforms |
Q35815393 | In vitro fertilization. Technology and methods. |
Q35178937 | Inactivation Of Microbial Contaminants Of Blood Components |
Q38021117 | Inborn errors of metabolism and their status in India |
Q39662404 | Individualization of drug dosage regimens |
Q38500721 | Infections by Intestinal Coccidia and Giardia duodenalis |
Q35173126 | Infections in patients with cystic fibrosis: diagnostic microbiology update |
Q54389249 | Infectious and zoonotic disease testing in pet birds. |
Q34588082 | Infectious diseases manifested in the peripheral blood |
Q38642418 | Infectious hazards in the clinical laboratory: a program to protect laboratory personnel |
Q51808920 | Inflammatory Dermatopathology for General Surgical Pathologists. |
Q36580199 | Inflammatory and long-term risk markers |
Q36062643 | Inflammatory markers of disease severity in acute pancreatitis |
Q64127535 | Influenza |
Q41281392 | Informatics applications in blood banking |
Q37147348 | Informatics tools for quality in anatomic pathology |
Q41729721 | Informatics. Using the Internet for forensic sciences. |
Q33558665 | Information for medical decision making. Improving our laboratory reports |
Q37733306 | Information workstations in clinical pathology. |
Q52515628 | Ingestions Considered Nontoxic |
Q38108955 | Inherited thrombophilia: diagnosis and anticoagulation treatment in pregnancy |
Q36843096 | Innovative methods in laboratory medicine resident teaching |
Q39662414 | Instrumentation and techniques for therapeutic drug monitoring |
Q70252854 | Instrumentation and techniques for therapeutic drug monitoring |
Q39551549 | Instrumentation for STAT analyses. |
Q69899689 | Instruments for microbial identification |
Q85919510 | Integrated quality control: implementation and validation of instrument function checks and procedural controls for a cartridge-based point-of-care system for critical care analysis |
Q91619903 | Integrating Decision Support into a Laboratory Utilization Management Program |
Q39551569 | Integrating automation into the clinical laboratory. |
Q78046138 | Integrating integrated laboratory information into health care delivery systems |
Q34914129 | Integration of technology into clinical practice. |
Q40937852 | Interactions between alcohol and hepatitis viruses in the liver. |
Q35780715 | Interferences in hormone immunoassays |
Q41101467 | Interferon and other therapies for hepatitis B and hepatitis C infections. |
Q38214190 | Interferon-gamma release assays |
Q38021122 | International reference laboratories |
Q37961248 | Interpretation of copy number alterations identified through clinical microarray-comparative genomic hybridization |
Q68970837 | Interpretation of electrophoretic patterns of serum proteins |
Q69885639 | Interpretation of gamma-glutamyltransferase isoenzyme electrophoretic patterns |
Q69588691 | Interpretation of lactate dehydrogenase isoenzymes |
Q70250081 | Interpretive reporting |
Q71388865 | Interpretive reporting |
Q71033703 | Interpretive toxicology |
Q64126209 | Intestinal amebae |
Q33767353 | Intestinal amebae. |
Q30957843 | Intestinal microsporidiosis |
Q36322446 | Intraoperative imprint cytology in assessment of sentinel lymph nodes and lumpectomy surgical margins |
Q33685805 | Intrauterine fetal diagnosis for hematologic and other congenital disorders |
Q30445397 | Introduction to data mining for medical informatics |
Q30445393 | Introduction to the mining of clinical data |
Q88731141 | Introduction: Molecular Medicine in the Common Era: Applications and Impact of Molecular Pathology in Health and Disease |
Q46849490 | Introduction: the impact of molecular pathology on the practice of pathology |
Q38127928 | Invasive fungal infections: biomarkers and molecular approaches to diagnosis |
Q45159485 | Invasive techniques for the diagnosis of respiratory infections |
Q38847008 | Inverted Pyramid of Care |
Q77802867 | Iron and copper-associated cirrhosis in infants. Acquired metal toxicity or genetic disorder? |
Q36243601 | Islet cells replacement therapy |
Q68883274 | Issues and trends in the regulation of office-based clinical laboratories |
Q90985818 | It's Mass Spectrometry's Turn to Change Clinical Practice |
Q39008444 | Ketamine: A Cause of Urinary Tract Dysfunction |
Q39551555 | Knowledge-based automation |
Q77802860 | LC/MS with a particle beam interface in forensic toxicology |
Q50140514 | Laboratories as the Core for Health Systems Building |
Q53943225 | Laboratories in patient-centered units. |
Q91021915 | Laboratory Assays of Immune Cell Function in Immunodeficiencies |
Q34715238 | Laboratory Diagnosis of Cysticercosss |
Q37007640 | Laboratory Diagnosis of Filariasis |
Q37007605 | Laboratory Diagnosis of Giardiasis |
Q37007622 | Laboratory Diagnosis of Leishmania |
Q37007607 | Laboratory Diagnosis of Pathogenic Free-Living Amoebas: Naegleria, Acanthamoeba, and Leptomyxid |
Q72675817 | Laboratory Diagnosis of Pneumocystis carinii Infection |
Q37007630 | Laboratory Diagnosis of Pneumocystosis |
Q37007614 | Laboratory Diagnosis of Trypanosomiasis |
Q39182991 | Laboratory Diagnosis of Worms and Miscellaneous Specimens |
Q91021900 | Laboratory Evaluation of Antiphospholipid Syndrome: An Update on Autoantibody Testing |
Q38724923 | Laboratory Information Systems |
Q38724933 | Laboratory Information Systems Management and Operations |
Q38924930 | Laboratory Medicine in the Clinical Decision Support for Treatment of Hypercholesterolemia: Pharmacogenetics of Statins |
Q41442468 | Laboratory Planning and Design |
Q91021932 | Laboratory Testing in the Context of Biologics and Cellular Therapies |
Q81471246 | Laboratory accreditation and inspection |
Q35671430 | Laboratory and genetic assessment of iron deficiency in blood donors |
Q70168303 | Laboratory and hospital information systems |
Q37961252 | Laboratory aspects of prenatal microarray analysis |
Q40603707 | Laboratory assessment of circulating anticoagulants. |
Q40192044 | Laboratory assessment of coagulation disorders in liver disease. |
Q40485824 | Laboratory assessment of prostate status |
Q36976836 | Laboratory automation: total and subtotal |
Q37147352 | Laboratory clinical effectiveness: pathologists improving clinical outcomes |
Q71704549 | Laboratory computerization. A new analysis of workflow and reporting |
Q93670792 | Laboratory computers: tools for increased productivity |
Q40751687 | Laboratory detection of anaerobic bacteremia. |
Q39669313 | Laboratory detection of cannabinoids. |
Q40751738 | Laboratory detection of fungemia |
Q40751743 | Laboratory detection of mycobacteremia. |
Q38127925 | Laboratory detection of sepsis: biomarkers and molecular approaches |
Q35029090 | Laboratory diagnosis of Bartonella infections. |
Q67711582 | Laboratory diagnosis of amebiasis |
Q40544886 | Laboratory diagnosis of antiphospholipid syndromes. |
Q35815466 | Laboratory diagnosis of fetal infections |
Q39162265 | Laboratory diagnosis of herpesvirus infections. |
Q38695483 | Laboratory diagnosis of human immunodeficiency virus infection. |
Q71438550 | Laboratory diagnosis of infections caused by Legionella species |
Q33306333 | Laboratory diagnosis of malaria |
Q49302148 | Laboratory diagnosis of male infertility |
Q38500703 | Laboratory diagnosis of noroviruses: present and future |
Q37007624 | Laboratory diagnosis of toxoplasmosis |
Q40603702 | Laboratory diagnosis of von Willebrand's disease. |
Q40196391 | Laboratory evaluation of hyper- and hypoglycemic states |
Q37576585 | Laboratory evaluation of hypercoagulability. |
Q40891541 | Laboratory evaluation of magnesium status. Renal function and free intracellular magnesium concentration. |
Q40544843 | Laboratory evaluation of platelet dysfunction |
Q40891506 | Laboratory evaluation of renal tubular acidosis. |
Q70670720 | Laboratory evaluation of the bleeding patient |
Q36436430 | Laboratory evaluations of infections in immunosuppressed transplant patients. |
Q37733341 | Laboratory information systems from a perspective of continuing evolution |
Q40891551 | Laboratory investigation of renal stone disease |
Q40817224 | Laboratory methods for the detection of hemoglobinopathies in the community hospital |
Q40603714 | Laboratory monitoring of new antithrombotic drugs |
Q37435542 | Laboratory monitoring of nonrenal allograft rejection. |
Q40603709 | Laboratory monitoring of oral anticoagulant therapy. |
Q37435613 | Laboratory monitoring of therapy with OKT3 and other murine monoclonal antibodies |
Q40544860 | Laboratory monitoring of thrombolytic therapy |
Q33489880 | Laboratory monitoring of unfractionated heparin treatment. |
Q36976838 | Laboratory quality management: a roadmap |
Q37576572 | Laboratory testing for von Willebrand disease: toward a mechanism-based classification |
Q68034308 | Laboratory testing in organ transplantation. Laboratory management: Regulation of clinical laboratories |
Q38730442 | Lactate dehydrogenase isoenzymes in myocardial disease |
Q68623774 | Lead |
Q40631545 | Lead poisoning--Part I. Incidence, etiology, and toxicokinetics. |
Q40559587 | Lead poisoning--Part II. Effects and assay |
Q35178942 | Legal Issues in Transfusion Medicine: Is Blood Banking a Medical Profession? |
Q43443023 | Legal aspects of laboratory medicine |
Q41281381 | Legal issues in blood banking. Elements of informed consent |
Q89488273 | Lessons Learned from Direct-to-Consumer Genetic Testing |
Q39467398 | Leukemias and lymphomas of thymic differentiation |
Q38020608 | Leukemias of indeterminant lineage |
Q38581030 | Leukocyte differentials. Are they worth the effort? |
Q71388872 | Limitations and value of aspiration cytology |
Q35178931 | Limiting Homologous Blood Exposure |
Q35815421 | Linkage analysis and predicting genetic disease |
Q71704539 | Linking laboratory and hospital information systems: the modular approach |
Q34231407 | Lipid disorders in type 1 and type 2 diabetes. |
Q34582291 | Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy. |
Q36655571 | Lipoprotein(a): a unique risk factor for cardiovascular disease. |
Q36580220 | Lipoprotein-associated phospholipase A2. |
Q90985804 | Liquid Chromatography-Mass Spectrometry Education for Clinical Laboratory Scientists |
Q39008401 | Liquid Chromatography-Tandem Mass Spectrometry: An Emerging Technology in the Toxicology Laboratory |
Q39669291 | Lithium monitoring |
Q34231425 | Liver disease and diabetes mellitus. |
Q37576578 | Liver disease, coagulation testing, and hemostasis |
Q34755462 | Liver function: test selection and interpretation of results |
Q41101426 | Liver regeneration in health and disease. |
Q88731177 | Looking Good in Your Genes: Maximizing One's Personalized Molecular Fingerprint for Optimal Health |
Q38608995 | Lowering blood cholesterol to reduce coronary heart disease risk |
Q34502551 | Lyme Disease Coinfections in the United States |
Q38642893 | Lyme Disease Diagnosis: Serology |
Q84332803 | Lyme disease |
Q39637076 | Lymphocytic surface markers in lymphoid leukemoid reactions |
Q50140468 | Lymphoma and Pathology in Sub-Saharan Africa: Current Approaches and Future Directions |
Q37961262 | Lymphoma cytogenetics |
Q91619946 | Machine Learning and Other Emerging Decision Support Tools |
Q35792500 | Macrolide resistance in Streptococci and Haemophilus influenzae. |
Q71438540 | Macroscopic and microscopic evaluation of respiratory specimens |
Q93013095 | Maintaining the Health of the Renal Allograft: Laboratory and Histologic Monitoring After Kidney Transplantation |
Q93670788 | Maintaining the quality of laboratory services in a cost-containment environment |
Q30342744 | Major factors affecting the emergence and re-emergence of infectious diseases. |
Q84442630 | Major issues faced by laboratories in India |
Q38571534 | Making Sense of Lymphoma Diagnostics in Small Animal Patients |
Q34914073 | Maldi-tof mass spectrometry for microorganism identification |
Q37147362 | Malpractice in dermatopathology: principles, risk mitigation, and opportunities for improved care for the histologic diagnosis of melanoma and pigmented lesions |
Q30653842 | Management of a point-of-care program. Organization, quality assurance, and data management. |
Q39937489 | Management of a point-of-care testing program |
Q38244370 | Management of anticoagulation agents in trauma patients |
Q38244377 | Management of anticoagulation and hemostasis for pediatric extracorporeal membrane oxygenation |
Q38108948 | Management of pregnant patients with diabetes with ischemic heart disease |
Q38695517 | Managing hazardous waste in the clinical laboratory |
Q36976832 | Managing laboratory test use: principles and tools |
Q71673496 | Managing physician use of laboratory tests |
Q40161871 | Managing the laboratory technical workforce |
Q38005551 | Mandatory drug testing in the United States. Opportunities and challenges for the medical review officer. |
Q40751697 | Manual blood culture systems and the antimicrobial removal device. |
Q92427201 | Mapping the Road to the Future: Training the Next Generation of Clinical Microbiologists, from Technologist to Laboratory Director |
Q38500696 | Markers of intestinal inflammation for the diagnosis of infectious gastroenteritis |
Q40246671 | Mass screening for cancer: the interpretation of findings and the prediction of effects on morbidity and mortality. |
Q84928503 | Mass spectrometry continues its march into the clinical laboratory |
Q84928514 | Mass spectrometry for clinical toxicology: therapeutic drug management and trace element analysis |
Q70639095 | Massive transfusion |
Q71919364 | Massive transfusion |
Q50059648 | Mast Cell Disease Assessment by Flow Cytometric Analysis |
Q38847019 | Maternal Serum Analytes as Predictors of Fetal Growth Restriction with Different Degrees of Placental Vascular Dysfunction |
Q35815489 | Maternal immunity to red cell antigens and fetal transfusion |
Q33407935 | Maternal thrombocytopenia in pregnancy: diagnosis and management |
Q41281357 | Mathematical calculations in transfusion medicine |
Q52716100 | Mathematical models used to assess laboratory and other measurements in patients with cancer. Biological time series and multivariate analysis. |
Q90985784 | Matrix-Assisted Laser Desorption Time of Flight Mass Spectrometry |
Q92427163 | Matrix-Assisted Laser Desorption/Ionization Time-of-Flight: The Revolution in Progress |
Q38609026 | Measurement of cholesterol, triglycerides, and HDL using compact analysis systems |
Q38244366 | Measurement of dabigatran in standardly used clinical assays, whole blood viscoelastic coagulation, and thrombin generation assays |
Q35780767 | Measurement of parathyroid hormone and application of parathyroid hormone in intraoperative monitoring |
Q38609018 | Measurement of total cholesterol, HDL-cholesterol, and LDL-cholesterol |
Q36580209 | Measures of insulin sensitivity |
Q36580201 | Measures of oxidative stress |
Q36580217 | Measures of thrombosis and fibrinolysis. |
Q39116093 | Measuring Analytical Quality: Total Analytical Error Versus Measurement Uncertainty |
Q37147357 | Measuring quality in anatomic pathology |
Q101119150 | Measuring the Serologic Response to Severe Acute Respiratory Syndrome Coronavirus 2: Methods and Meaning |
Q40165898 | Mechanisms of Acute Lung Injury |
Q35792494 | Mechanisms of resistance among respiratory tract pathogens |
Q37942245 | Mechanisms of toxic cell injury. |
Q40108738 | Mediators of Anaphylaxis |
Q36976842 | Medical laboratory informatics |
Q36525313 | Medical strategies to handle mass casualties from the use of biological weapons |
Q38021121 | Medical tourism in India |
Q36322435 | Medical-legal issues associated with breast fine needle aspiration biopsy |
Q77316049 | Medicolegal issues and fine needle aspiration of the breast. What you can do to decrease your risk of being sued |
Q37872868 | Melanoma margin assessment |
Q36105178 | Metanephric neoplasms: the hyperdifferentiated, benign end of the Wilms tumor spectrum? |
Q54352572 | Methicillin-resistant staphylococci. |
Q129482741 | Methicilln-Resistant Staphylococci |
Q39662443 | Methodologies for antidepressant monitoring. |
Q38186264 | Methodologies for measurement of cardiac markers |
Q41159587 | Methods for the rapid identification of mycobacterial species |
Q36239012 | Methods to Evaluate and Develop the Decision Process in the Selection of Tests |
Q38642907 | Methods to Prevent Tick Bites and Lyme Disease |
Q37787464 | Methods: Genetic Epidemiology |
Q39116101 | Metrological Traceability of Assays and Comparability of Patient Test Results |
Q91310589 | MicroRNAs and Transplantation |
Q70214022 | Microalbuminuria |
Q80180389 | Microalbuminuria |
Q37457327 | Microarrays in glycoproteomics research |
Q37332936 | Microarrays: monitoring for transplant tolerance and mechanistic insights |
Q37904042 | Microbial diagnosis by nucleic acid sandwich hybridization. |
Q34480117 | Microbiology. |
Q70252835 | Microbiology: microbial antigen detection |
Q34626014 | Microbiome in human immunodeficiency virus infection |
Q34625513 | Microbiome, innate immunity, and esophageal adenocarcinoma. |
Q70250087 | Microcomputer Technology |
Q69899686 | Microdilution and agar replica identification test systems |
Q36062657 | Microsatellite instability and DNA mismatch repair deficiency testing in hereditary and sporadic gastrointestinal cancers |
Q39605748 | Microscopic hematuria. |
Q34480064 | Microsphere-based molecular cytometry |
Q34163914 | Minimal deviation melanoma. Borderline and intermediate melanocytic neoplasia. |
Q40386579 | Minimal requirements for hematologic cytochemistry in the community hospital laboratory. |
Q33854477 | Minimal residual disease in acute promyelocytic leukemia |
Q39662449 | Misuse of therapeutic drug monitoring: an analysis of causes and methods for improvement. |
Q101119118 | Modern Blood Culture: Management Decisions and Method Options |
Q34755520 | Modern approaches to the investigation of vitamin B12 deficiency |
Q36894015 | Modern flow cytometry: a practical approach |
Q38846993 | Modifying Risk of Aneuploidy with a Positive Cell-Free Fetal DNA Result |
Q37773674 | Modifying risk for aneuploidy with second-trimester ultrasound after a positive serum screen |
Q36525337 | Modulating radiation resistance: Insights based on defenses against reactive oxygen species in the radioresistant bacterium Deinococcus radiodurans |
Q39639892 | Modulation of T-cell-mediated regulation of antibody production by interaction with specific immune complexes |
Q88731153 | Molecular Diagnosis of Hematopoietic Neoplasms: 2018 Update |
Q91021941 | Molecular Diagnosis of Inherited Immune Disorders |
Q88731157 | Molecular Diagnostics in Colorectal Carcinoma: Advances and Applications for 2018 |
Q54206402 | Molecular Diagnostics in Esophageal and Gastric Neoplasms: 2018 Update. |
Q88731159 | Molecular Diagnostics in the Neoplasms of Small Intestine and Appendix: 2018 Update |
Q88731163 | Molecular Diagnostics in the Neoplasms of the Pancreas, Liver, Gallbladder, and Extrahepatic Biliary Tract: 2018 Update |
Q54150941 | Molecular Melanoma Diagnosis Update: Gene Fusion, Genomic Hybridization, and Massively Parallel Short-Read Sequencing. |
Q38724936 | Molecular Pathology Informatics |
Q88731144 | Molecular Pathology Techniques: Advances in 2018 |
Q88731150 | Molecular Pathology in Transfusion Medicine: New Concepts and Applications |
Q81481267 | Molecular and genetic aspects of gastrointestinal and pancreatic disease |
Q38127930 | Molecular approaches and biomarkers for detection of Mycobacterium tuberculosis |
Q41161240 | Molecular approaches for the diagnosis of 21-hydroxylase deficiency and congenital adrenal hyperplasia. |
Q37872873 | Molecular aspects of melanoma |
Q41136685 | Molecular basis of genetic disease and molecular methods |
Q40631497 | Molecular biology of HIV. |
Q35623129 | Molecular detection and typing of fungal pathogens |
Q35623155 | Molecular detection of infections associated with neoplasia |
Q35623138 | Molecular detection of resistance to antituberculous therapy |
Q38127926 | Molecular detection of respiratory viruses |
Q33854484 | Molecular diagnosis in pediatric acute leukemias |
Q71608390 | Molecular diagnosis of cystic fibrosis |
Q38165301 | Molecular diagnosis of hematopoietic neoplasms |
Q81481276 | Molecular diagnosis of solid and cystic lesions of the pancreas |
Q38214188 | Molecular diagnosis of tuberculosis and drug resistance |
Q35623141 | Molecular diagnosis of viral infections of the central nervous system |
Q38127927 | Molecular diagnostics and parasitic disease |
Q40901914 | Molecular diagnostics for cystic fibrosis |
Q38165302 | Molecular diagnostics in colorectal carcinoma |
Q38165304 | Molecular diagnostics in esophageal and gastric neoplasms |
Q37576587 | Molecular diagnostics in hemostatic disorders |
Q38165303 | Molecular diagnostics in the neoplasms of small intestine and appendix |
Q38165305 | Molecular diagnostics in the neoplasms of the pancreas, liver, gall bladder, and extrahepatic biliary tract |
Q35623150 | Molecular epidemiology in the public health and hospital environments |
Q37904000 | Molecular epidemiology of bacterial infections. |
Q41136726 | Molecular genetic advances in neurodegenerative disorders. |
Q37919281 | Molecular genetic approaches for the diagnosis of clonality in lymphoid neoplasms |
Q35171709 | Molecular genetic testing for prenatal diagnosis |
Q36105155 | Molecular genetics of familial renal cell carcinoma syndromes |
Q36062661 | Molecular markers in Helicobacter pylori-associated gastric carcinogenesis |
Q35560090 | Molecular markers in cervical cytology |
Q40544875 | Molecular markers of hemostatic activation. Implications in the diagnosis of thrombosis, vascular, and cardiovascular disorders |
Q33854461 | Molecular mechanisms in myelodysplastic syndromes and implications for evolution to acute leukemias. |
Q40772927 | Molecular mechanisms of thyroid hormone action |
Q40772931 | Molecular mechanisms of thyroid hormone action. A physiologic perspective. |
Q35623146 | Molecular methods for ehrlichiosis and Lyme disease |
Q38020619 | Molecular methods to detect the Philadelphia chromosome. |
Q54549213 | Molecular pathology in the modern era: revisiting Jacob's spotted sheep. |
Q38165300 | Molecular pathology in transfusion medicine |
Q38165297 | Molecular pathology techniques |
Q41101450 | Molecular variants of hepatitis B virus. |
Q36691337 | Monitoring HLA alloimmunization. Analysis of HLA alloantibodies in the serum of prospective transplant recipients. |
Q39669281 | Monitoring aminoglycoside therapy |
Q33779490 | Monitoring anatomic pathology practice through quality assurance measures. |
Q39669294 | Monitoring cyclic antidepressants |
Q39669328 | Monitoring of anti-inflammatory drugs |
Q71120056 | Monitoring of fetal scalp pH |
Q37773667 | Monitoring quality control of nuchal translucency |
Q39829627 | Monoclonal antibodies for bacterial identification and taxonomy: 1985 and beyond. |
Q37904038 | Monoclonal antibodies for the diagnosis of sexually transmitted diseases. |
Q36238989 | Monoclonal antibodies in cancer immunotherapy |
Q39525554 | Monoclonal antibodies: use in urine sediment examination |
Q36894060 | More than just quality control |
Q33854443 | Morphology and classification of acute myeloid leukemias. |
Q30445401 | Multi-database mining |
Q38642374 | Multicategory interpretive reporting of susceptibility testing with selected antimicrobial concentrations. Ten years of laboratory and clinical experience |
Q40559571 | Multimedia communications networks. Patient care through interactive point-of-care testing. |
Q37961260 | Multiple myeloma: current perspectives |
Q33365957 | Multiple sclerosis: neuroimmunologic puzzle |
Q37885393 | Multiplex polymerase chain reaction for the diagnosis of sexually transmitted diseases |
Q26829787 | Multiplex polymerase chain reaction tests for detection of pathogens associated with gastroenteritis |
Q82686483 | Myelodysplastic syndromes |
Q51808939 | Myeloid Neoplasms. |
Q36894043 | Myeloid malignancies: myelodysplastic syndromes, myeloproliferative disorders, and acute myeloid leukemia |
Q68649874 | Myeloproliferative disorders |
Q33401917 | Myeloproliferative disorders. Classification and diagnostic features with special emphasis on chronic myelogenous leukemia and agnogenic myeloid metaplasia |
Q40935825 | Myometrial and stromal lesions of the uterus. |
Q41161225 | NASBA: a novel, isothermal detection technology for qualitative and quantitative HIV-1 RNA measurements. |
Q83461330 | Nanobiotechnology-based cancer diagnosis. Preface |
Q40148315 | Nanoporous noninvasive cellular electrical activity-based analysis devices. |
Q39008398 | Narcotic Analgesics and Common Drugs of Abuse: Clinical Correlations and Laboratory Assessment |
Q38186253 | Natriuretic peptides in heart failure and acute coronary syndrome |
Q68039963 | Neonatal alloimmune thrombocytopenia |
Q40335885 | Neonatal hypocalcemia and related conditions. |
Q40772950 | Neonatal screening for congenital hypothyroidism. |
Q39637064 | Neoplasms of terminally differentiated B lymphocytes |
Q36105170 | Nephroblastic neoplasms |
Q37942246 | Nephrotoxic and ototoxic agents |
Q54716615 | Nervous System Lyme Disease. |
Q71677004 | Networking pathology services: adjusting to managed care |
Q30724585 | Neuropathogenesis of central nervous system HIV-1 infection |
Q48627307 | Neurotoxicity of certain environmental substances |
Q40165905 | Neutral Proteinases from Human Inflammatory Cells: A Critical Review of Their Role in Extracellular Matrix Degradation |
Q37872861 | Nevi of special sites |
Q33891777 | Nevoid melanoma |
Q40480558 | New Aspects of Emerging Fungal Pathogens: A Multifaceted Challenge |
Q36238997 | New Developments in Flow Cytometric Analyses of Lymphocyte Markers |
Q128455677 | New Pipeline of Immunoregulatory Molecules and Biomarkers in Transplantation |
Q35178930 | New Testing Approaches in Transfusion Medicine |
Q36936971 | New concepts in diabetic embryopathy |
Q40935836 | New developments in sex cord-stromal and germ cell tumors of the ovary |
Q36433126 | New drugs of abuse in North America |
Q38609006 | New guidelines for lowering blood cholesterol |
Q35999827 | New markers in serum for lymphocyte activation for predicting allograft rejection. Neopterin and soluble interleukin-2 receptor |
Q34875935 | New methods for the detection of HIV. |
Q38186262 | New molecular genetic tests in the diagnosis of heart disease |
Q38244371 | New oral anticoagulant-induced bleeding: clinical presentation and management |
Q39551526 | New technologies in chemistry instrumentation: the basis for clinical chemistry automation. |
Q40935877 | New therapeutic approaches in gynecologic oncology. |
Q129481470 | Newer Cardiae Agents: Antiarrhythmics and Antianginal Agents |
Q39669301 | Newer cardiac agents: antiarrhythmics and antianginal agents |
Q92427169 | Next-Generation Sequencing in Clinical Microbiology: Are We There Yet? |
Q36322440 | Nipple fluid cytology |
Q33948301 | Nongenital human papillomavirus infections. |
Q39868111 | Noninvasive fetal blood grouping: present and future |
Q80116214 | Noninvasive fluid property measurements using acoustic methods |
Q37773672 | Noninvasive prenatal diagnosis: 2010. |
Q39470138 | Noninvasive renal diagnostic studies |
Q34755602 | Noninvasive testing in the clinical laboratory |
Q38214189 | Nonmolecular methods for the diagnosis of respiratory fungal infections. |
Q38214187 | Nontuberculous mycobacteria in respiratory infections: advances in diagnosis and identification |
Q39637039 | Normal B-lineage cells: their differentiation and identification |
Q33767370 | Norwalk and "Norwalk-like viruses" in epidemic gastroenteritis |
Q71438556 | Nosocomial respiratory infection: The essential role of the laboratory in control efforts |
Q101119143 | Novel Assays/Applications for Patients Suspected of Mycobacterial Diseases |
Q91310599 | Novel Targets of Immunosuppression in Transplantation |
Q40963330 | Novel methods of DNA analysis |
Q37332931 | Novel noninvasive assays to predict transplantation rejection and tolerance: enumeration of cytokine-producing alloreactive T cells |
Q33420362 | Novel parameters in blood cell counters |
Q39551563 | Nuclear magnetic resonance: principles and applications to pathology |
Q39829621 | Nucleic acid hybridization in the diagnosis of viral infections |
Q72801071 | Nutrition and aging |
Q40819833 | Nutrition in the clinical laboratory |
Q40819864 | Nutrition in the management of inborn errors of metabolism |
Q40819873 | Nutritional status and immune responses. |
Q70615965 | Observations on the current status of poison control centers in the United States |
Q70615962 | Occupational disease. Problems of risk assessment |
Q69544173 | Office practice of laboratory medicine |
Q36105167 | Oncocytic renal neoplasms: diagnostic considerations |
Q39729736 | Oncogenes and human neoplasia |
Q85222909 | Ongoing technological revolution. Preface |
Q37733326 | Open systems architecture. The multivendor hospital information system |
Q31142725 | Open-source tools for data mining |
Q91619889 | Operational Aspects of a Clinical Decision Support Program |
Q43493486 | Opportunistic fungal infection: What the clinician, pathologist, and mycologist can accomplish if they work together |
Q37147341 | Opportunities to improve quality in laboratory medicine |
Q39450246 | Optical considerations in digital imaging. |
Q97900007 | Optimizing Genetic Diagnosis of Neurodevelopmental Disorders in the Clinical Setting |
Q36894021 | Optimizing a multicolor immunophenotyping assay |
Q38500683 | Optimizing the Laboratory Diagnosis of Clostridium difficile Infection |
Q71120062 | Organization of a laboratory service for therapeutic drug monitoring |
Q41681908 | Organizing hospital laboratories for efficiency and quality. |
Q39008451 | Otolaryngology Concerns for Illicit and Prescription Drug Use. |
Q92427219 | Our Pathogens Are Not Standing Still and Neither Can We |
Q31033562 | Overview and application of suspension array technology. |
Q38724949 | Overview of Telepathology |
Q87254173 | Overview of cardiac markers in heart disease |
Q37342097 | Overview of pharmacogenetics in anticoagulation therapy |
Q38039685 | Overview of progress in clinical toxicology testing |
Q70380801 | Overview of the pathology of pulmonary emphysema in the human |
Q38590661 | Packaged commercial bacterial identification systems |
Q90985779 | Pain Management Testing by Liquid Chromatography Tandem Mass Spectrometry |
Q101119119 | Panels and Syndromic Testing in Clinical Microbiology |
Q34032535 | Parathyroid hormone. Does it have a role in the pathogenesis of osteoporosis? |
Q50059652 | Paroxysmal Nocturnal Hemoglobinuria Assessment by Flow Cytometric Analysis |
Q40935862 | Pathobiology of human papillomavirus. |
Q38642396 | Pathogenic protozoa: an overview of in vitro cultivation and susceptibility to chemotherapeutic agents |
Q40817242 | Pathologist review of the peripheral smear. A mandatory quality assurance activity? |
Q40187126 | Pathologist's role in product-related deaths |
Q50123506 | Pathologist's role in product-related deaths |
Q38724939 | Pathology Gross Photography: The Beginning of Digital Pathology |
Q35957810 | Pathology and patient safety: the critical role of pathology informatics in error reduction and quality initiatives |
Q33779525 | Pathology imaging on the Web. Extending the role of the pathologist as educator to patients |
Q71033673 | Pathology of injuries caused by high-velocity missiles |
Q38053213 | Pathology resident and fellow education in a time of disruptive technologies |
Q50140471 | Pathology-Based Research in Africa |
Q50140455 | Pathology: Central and Essential |
Q34032497 | Pathophysiology of osteoporosis |
Q34554240 | Patient data algorithms |
Q45899949 | Patient population controls. |
Q38075164 | Patient safety & post-analytical error |
Q35957834 | Patient safety in point-of-care testing |
Q37147343 | Patient safety: a macrosystems perspective |
Q40856637 | Patterns of injury. Blunt and sharp. |
Q34876113 | Pediatric HIV infection and treatment |
Q40751706 | Pediatric blood cultures. |
Q35264312 | Peptide immunoaffinity enrichment coupled with mass spectrometry for peptide and protein quantification |
Q70509709 | Performance characteristics of screening tests |
Q37909208 | Perinatal Nonbacterial Infections |
Q40819857 | Perinatal and pediatric nutrition. |
Q38244376 | Perioperative management of patients receiving new oral anticoagulants: an international survey |
Q34588091 | Peripheral blood film review. The demise of the eyecount leukocyte differential |
Q34588048 | Peripheral blood findings in chronic myeloproliferative disorders |
Q34588066 | Peripheral blood manifestations of lymphoma and solid tumors |
Q38244373 | Periprocedural management of patients on anticoagulants |
Q71098437 | Personnel management |
Q41136733 | Perspectives and molecular diagnosis of Duchenne and Becker muscular dystrophies |
Q41136711 | Perspectives and molecular diagnosis of the fragile X syndrome. |
Q67999569 | Perspectives on clinical laboratory automation |
Q84748312 | Perspectives on cost and outcomes for point-of-care testing |
Q35122315 | Perspectives on prion biology, prion disease pathogenesis, and pharmacologic approaches to treatment |
Q38075156 | Perspectives on quality control, risk management, and analytical quality management |
Q40891526 | Perturbations in potassium balance |
Q40891520 | Perturbations in sodium balance. Hyponatremia and hypernatremia. |
Q38214185 | Pertussis: relevant species and diagnostic update |
Q37342101 | Pharmacogenetic testing for warfarin sensitivity |
Q37342118 | Pharmacogenetic testing in psychiatry: a review of features and clinical realities. |
Q37342126 | Pharmacogenetic testing in schizophrenia and posttraumatic stress disorder |
Q37342130 | Pharmacogenetic tests in asthma therapy |
Q38832274 | Pharmacogenetics and Personalized Medicine in Pain Management |
Q37787471 | Pharmacogenetics and Schizophrenia |
Q38924925 | Pharmacogenetics in Oral Antithrombotic Therapy |
Q34896426 | Pharmacogenetics in pain management: the clinical need |
Q37342123 | Pharmacogenetics-guided dose modifications of antidepressants |
Q53122330 | Pharmacogenetics: from description to prediction. |
Q38039698 | Pharmacogenomics and the future of toxicology testing |
Q38924934 | Pharmacogenomics in Psychiatric Practice |
Q37342109 | Pharmacogenomics of tamoxifen and irinotecan therapies |
Q37332939 | Pharmacogenomics: the key to improved drug therapy in transplant patients |
Q37942243 | Pharmacokinetics of drug overdose. |
Q38244367 | Pharmacology and laboratory testing of the oral Xa inhibitors |
Q38244364 | Pharmacology and safety of new oral anticoagulants: the challenge of bleeding persists |
Q40087570 | Phenothiazines |
Q83461328 | Phosphorylcholine self-assembled monolayer-coated quantum dots: real-time imaging of live animals by cell surface mimetic glyco-nanoparticles |
Q40603689 | Physiology of hemostasis. |
Q39956783 | Physiology of hemostasis: with relevance to current and future laboratory testing |
Q36427869 | Pisse prophecy: a brief history of urinalysis |
Q72405495 | Pituitary tumors |
Q52703057 | Planning and instituting New Tests in the Clinical Laboratory |
Q70509705 | Plasma clearance of carcinoembryonic antigen and asialo carcinoembryonic antigen by the liver of the nutritionally deficient rhesus monkey |
Q39496488 | Plasmid fingerprinting. A tool for bacterial strain identification and surveillance of nosocomial and community-acquired infections |
Q37919290 | Plastic section immunohistochemistry in the diagnosis of hematopoietic and lymphoid neoplasms |
Q38020626 | Platelet abnormalities in myeloproliferative disorders |
Q33498065 | Platelet antibodies |
Q71919358 | Platelet transfusion therapy |
Q37576570 | Platelet-related bleeding: an update on diagnostic modalities and therapeutic options |
Q70506198 | Platelet-type von Willebrand's disease |
Q40165911 | Platelets and the Inflammatory Response |
Q38353374 | Platelets: the few, the young, and the active |
Q81471255 | Point of care testing |
Q101119133 | Point-of-Care Testing in Microbiology |
Q44605791 | Point-of-care testing and molecular diagnostics: miniaturization required |
Q43258761 | Point-of-care testing for cardiac markers in acute coronary syndromes and heart failure |
Q30227477 | Point-of-care testing for disasters: needs assessment, strategic planning, and future design |
Q39937476 | Point-of-care testing in coagulation |
Q39937482 | Point-of-care testing informatics |
Q34275941 | Point-of-care testing. An overview and a look to the future |
Q73983748 | Point-of-care testing. Cost issues and impact on hospital operations |
Q34275948 | Point-of-care testing. Impact on medical outcomes. |
Q84748304 | Point-of-care testing. Preface |
Q39937496 | Point-of-care testing: an overview and a look to the future (circa 2009, United States). |
Q36655583 | Polyacrylamide gradient gel electrophoresis of lipoprotein subclasses |
Q40246649 | Polyamines. The elusive cancer markers |
Q38020622 | Polycythemia vera and other polycythemic states |
Q40631533 | Polymerase chain reaction and HIV. |
Q41159593 | Polymerase chain reaction and other amplification techniques in mycobacteriology |
Q39662409 | Polymeric controlled release systems: new methods for drug delivery |
Q38005556 | Postmortem forensic toxicology |
Q41729728 | Postmortem identifications of remains. |
Q36655576 | Postprandial lipemia and remnant lipoproteins |
Q68970834 | Potential problems in serum protein electrophoresis |
Q101119122 | Practical Aspects and Considerations When Planning a New Clinical Microbiology Laboratory |
Q85948301 | Practical Interpretation and Application of Exocrine Pancreatic Testing in Small Animals |
Q48499570 | Practical Successes in Telepathology Experiences in Africa |
Q40817258 | Practical approach to the investigation of neutropenia |
Q40162941 | Preanaiytic Variables: A Management Problem |
Q95309657 | Precision Medicine Exits the Hype Cycle and Enters into Productive Clinical Use |
Q39008427 | Precision Medicine in Toxicology |
Q95309636 | Precision Therapy for Inherited Retinal Disease: At the Forefront of Genomic Medicine |
Q37836019 | Preclinical safety assessment: current gaps, challenges, and approaches in identifying translatable biomarkers of drug-induced liver injury |
Q92427188 | Predicting Bacterial Versus Viral Infection, or None of the Above: Current and Future Prospects of Biomarkers |
Q37787466 | Predictive and diagnostic genetic testing in psychiatry |
Q87958052 | Preface |
Q88106166 | Preface |
Q88761819 | Preface |
Q91310627 | Preface |
Q95457873 | Preface |
Q85201061 | Preface. Diagnostic testing for enteric pathogens |
Q49045662 | Preface. Genetics of neurologic and psychiatric diseases |
Q82850738 | Preface. Pharmacogenetics and its application to medicine by way of the clinical laboratory |
Q51820992 | Preface. Transfusion in the year 2020: the future of blood transfusion. |
Q82686490 | Preface: Cytogenetics |
Q84575505 | Preface: Prenatal screening and diagnosis |
Q33767350 | Preformed bacterial toxins |
Q38108949 | Pregnancy management of diabetic renal transplant patients |
Q37718643 | Preimplantation genetic testing: indications and controversies |
Q38847036 | Prenatal Screening for Thrombophilias: Indications and Controversies, an Update |
Q89305169 | Prenatal Screening: The Birth of a New Era |
Q35815425 | Prenatal genetics in laboratory medicine. A cytogeneticist's perspective |
Q35171691 | Prenatal screening for Down syndrome: current and future methods |
Q35171713 | Prenatal screening for cystic fibrosis |
Q35171687 | Prenatal screening for open neural tube defects |
Q37773679 | Prenatal screening for thrombophilias: indications and controversies |
Q35171695 | Prenatal screening, epidemiology, diagnosis, and management of preeclampsia |
Q35171671 | Prenatal testing for infectious disease |
Q41101474 | Prevention of liver cancer and cirrhosis by vaccines |
Q51808940 | Primary Cutaneous B-cell Lymphomas. |
Q34163906 | Primary noncutaneous melanoma. |
Q41159574 | Primary processing of specimens and isolation and cultivation of mycobacteria |
Q114197051 | Principles and Validation of Bioinformatics Pipeline for Cancer Next-Generation Sequencing |
Q38535059 | Principles and clinical applications of image analysis |
Q38039697 | Principles and procedures in forensic toxicology |
Q84332798 | Prion diseases |
Q38075160 | Prioritizing risk analysis quality control plans based on Sigma-metrics |
Q68883271 | Proficiency of office microbiology testing |
Q129481558 | Prognostic Value of Cytologic Peritoneal Wahings |
Q39827245 | Prognostic value of cytologic peritoneal washings |
Q36322451 | Prognostic/predictive factors in breast cancer |
Q37733339 | Programming languages. |
Q38642390 | Progress in standardizing antifungal susceptibility tests |
Q40614869 | Progress in the development of a preventive HIV-1 vaccine |
Q36843092 | Proposed research training guidelines for residents in laboratory medicine |
Q30579770 | Prospecting for gold in the data mine. |
Q40116249 | Prostaglandins and the Inflammatory Response |
Q40215163 | Prostaglandins in human disease. |
Q53159447 | Protecting animal and human health and the nation's food supply through veterinary diagnostic laboratory testing. |
Q40819846 | Proteins used in nutritional assessment |
Q70214018 | Proteinuria |
Q70633622 | Proteinuria |
Q90985789 | Proteoform Analysis to Fulfill Unmet Clinical Needs and Reach Global Standardization of Protein Measurands in Clinical Chemistry Proteomics |
Q30376407 | Proteomics and diabetic retinopathy. |
Q47954521 | Proteomics in laboratory medicine. Preface |
Q97900010 | Proteopathic Seed Amplification Assays for Neurodegenerative Disorders |
Q38244375 | Prothrombin complex concentrates as reversal agents for new oral anticoagulants: lessons from preclinical studies with Beriplex |
Q37576575 | Prothrombin time and partial thromboplastin time assay considerations |
Q73983773 | Provider-performed microscopy |
Q84748322 | Provider-performed microscopy |
Q37733333 | Providing integrated information resources to physicians' offices. |
Q41681915 | Prying questions about privacy in a nosy world. |
Q37253652 | Pulmonary cytology. |
Q37733328 | Putting bar codes to work for improved patient care. |
Q39116137 | Quality Indicators for the Total Testing Process. |
Q37147370 | Quality and safety in outpatient laboratory testing |
Q51205323 | Quality assurance in a large reference laboratory. |
Q39751394 | Quality assurance in anatomic pathology. |
Q44183368 | Quality assurance in drug testing laboratories. |
Q39799694 | Quality assurance in home laboratory testing |
Q41159608 | Quality assurance in the mycobacteriology laboratory. Quality control, quality improvement, and proficiency testing |
Q39525548 | Quality assurance in urinalysis. |
Q69689055 | Quality assurance of the analytic process: pre- and postanalytic variation |
Q44636464 | Quality control (QC) clinic. Preface |
Q69544201 | Quality control and quality assurance |
Q40559565 | Quality control and quality management of alternate-site testing. |
Q40162945 | Quality control for the clinical laboratory |
Q80688430 | Quality control in clinical flow cytometry |
Q39751400 | Quality control in cytopathology |
Q39751388 | Quality control in hematology. |
Q39751383 | Quality control in microbiology: a review and bibliography |
Q33460089 | Quality control in the blood bank. |
Q39751426 | Quality control in the office laboratory |
Q38353358 | Quality control of automated cell counters |
Q37147365 | Quality improvement in laboratory medicine: extra-analytical issues |
Q37147378 | Quality improvement opportunities in blood banking and transfusion medicine |
Q37147382 | Quality improvements in the preanalytical phase: focus on urine specimen workflow |
Q81151218 | Quality in laboratory medicine. Preface |
Q41461049 | Quantification of nucleic acids |
Q40891585 | Quantitation of renal function using radioisotopic techniques |
Q39839042 | Quantitative analysis of cost-savings strategies in the clinical laboratory. |
Q33685770 | Quantitative and qualitative platelet disorders |
Q34480071 | Quantitative flow cytometry |
Q44483962 | Quantitative urine levels of abusable drugs for clinical purposes |
Q37984868 | RNA quantification with gold nanoprobes for cancer diagnostics |
Q40480566 | Rapid Diagnosis of Viral Pathogens |
Q41687628 | Rapid MB CK subform assay and the early diagnosis of myocardial infarction |
Q92427057 | Rapid Susceptibility Testing Methods |
Q40751714 | Rapid detection and identification of microorganisms from blood cultures |
Q38214192 | Rapid diagnosis of influenza: state of the art. |
Q37903000 | Rapid methods in microbiology for in-office testing |
Q36894056 | Rare-event analysis in flow cytometry |
Q68858981 | Rates of drug detection in urine samples from various populations |
Q35780758 | Rational use of the laboratory for childhood and adult growth hormone deficiency |
Q78046135 | Re-engineering the clinical laboratory. An overview |
Q95598940 | Recent Advancements in the Assessment of Renal Transplant Dysfunction with an Emphasis on Microarray Molecular Diagnostics |
Q71649640 | Recent advances in blood groups |
Q35623133 | Recent advances in laboratory procedures for pathogenic mycobacteria |
Q38160857 | Recent advances in laboratory tests and the significance of autoantibodies to nuclear antigens in systemic rheumatic diseases. |
Q39639885 | Recent advances in laboratory tests for autoantibodies to thyrotropin receptor protein in Graves' disease. |
Q34381205 | Recent challenges in infectious diseases. Biological pathogens as weapons and emerging endemic threats. |
Q39868096 | Recent developments and future directions of alloimmunization to transfused blood products. |
Q54516894 | Recent developments in the diagnosis and management of mycobacterial infections. |
Q35011434 | Recently discovered human coronaviruses |
Q40112440 | Receptor Measurements |
Q37904613 | Recombinant DNA and other direct specimen identification techniques |
Q40751692 | Recovery of select rare and fastidious microorganisms from blood cultures. |
Q51480832 | Recreational drugs. Current trends in the 90s. |
Q26827130 | Red blood cell population dynamics |
Q34588074 | Red cell morphology and the peripheral blood film |
Q41281300 | Red cells and platelets. Modifications for special patients |
Q35178940 | Redefining and expanding quality assurance |
Q97900023 | Reference Laboratory Testing for Neurologic Disorders |
Q71388868 | Reference values: are they useful? |
Q30445403 | Regional and national health care data repositories |
Q36243618 | Regulation of eye banking and uses of ocular tissue for transplantation |
Q91310585 | Regulatory T Cells for More Targeted Immunosuppressive Therapies |
Q91310595 | Regulatory and Effector B Cells: A New Path Toward Biomarkers and Therapeutic Targets to Improve Transplant Outcomes? |
Q35178948 | Regulatory and Legislative Issues in Transfusion Medicine |
Q40559580 | Regulatory and accreditation implications of alternate-site laboratory testing |
Q73983733 | Regulatory compliance for point-of-care testing. A perspective from the United States (Circa 2000) |
Q30381771 | Regulatory compliance for point-of-care testing: 2009 United States perspective. |
Q84928521 | Regulatory considerations for clinical mass spectrometry: multiple reaction monitoring |
Q38039700 | Regulatory issues in accreditation of toxicology laboratories |
Q38642902 | Relapsing Fever Borreliae: A Global Review |
Q40187108 | Relationship between dose and health effects |
Q68039955 | Reproductive medicine and the clinical laboratory |
Q85948315 | Reptile Hematology |
Q30882265 | Rescreening in cervical cytology for quality control. When bad data is worse than no data or what works, what doesn't, and why. |
Q36843109 | Resident and fellow training in transfusion medicine |
Q36430204 | Resident training in clinical chemistry |
Q36843116 | Resident training in laboratory hematology |
Q36843120 | Resident training in microbiology |
Q36843129 | Resident training in point-of-care testing |
Q41161249 | Resistance to activated protein C and a novel factor V gene mutation. |
Q72561670 | Resistance to thyroid hormone |
Q70380797 | Resources available for patient evaluation |
Q71861034 | Respiratory distress syndrome, fetal pulmonary surfactant, and amniotic fluid phospholipid analysis |
Q38214191 | Respiratory fungal infections: molecular diagnostic tests |
Q51721752 | Respiratory infections. |
Q84854616 | Respiratory syncytial virus vaccine development |
Q33605739 | Respiratory viruses in bronchiolitis and their link to recurrent wheezing and asthma |
Q84854600 | Respiratory viruses in pediatric and adult populations. Preface |
Q34588103 | Reticulocytes. Their usefulness and measurement in peripheral blood |
Q95517366 | Retraction |
Q34445091 | Review of Testing for Human Immunodeficiency Virus |
Q38273534 | Review of the emerging treatment of Clostridium difficile infection with fecal microbiota transplantation and insights into future challenges |
Q39116145 | Rhetoric Versus Reality? Laboratory Surveys Show Actual Practice Differs Considerably from Proposed Models and Mandated Calculations |
Q39429610 | Rheumatoid arthritis: etiopathogenetic considerations |
Q30234603 | Rickettsiae as Emerging Infectious Agents |
Q52665091 | Rift Valley Fever. |
Q71676992 | Risk assessment and presymptomatic molecular diagnosis in hereditary breast cancer |
Q34032514 | Risk assessment for osteoporosis. II. Biochemical markers of bone turnover: bone resorption indices |
Q81471251 | Risk management and compliance in pathology and laboratory medicine |
Q30461586 | Robotics in the clinical laboratory. |
Q129466458 | Role of Thyrotropin Measurements in the Diagnosis and Management of Thryoid Disease |
Q41605531 | Role of autoantibody tests in the diagnostic evaluation of neuropsychiatric systemic lupus erythematosus. |
Q36894051 | Role of flow cytometry in the diagnosis and monitoring of primary immunodeficiency disease |
Q40819883 | Role of free radicals in cancer and atherosclerosis. |
Q37984869 | Role of nanodiagnostics in personalized cancer therapy |
Q42088248 | Role of the Emergency Physician in Treatment of the Poisoned Patient |
Q40772960 | Role of thyrotropin measurements in the diagnosis and management of thyroid disease |
Q33767374 | Rotavirus |
Q64126213 | Rotavirus |
Q35178912 | Safety in Transfusion Practices: Preventing Infectious Complications |
Q35178903 | Safety in Transfusion Practices: Red Cell Compatibility Testing Issues |
Q43323805 | Safety in the medical laboratory |
Q37457335 | Salivary biomarkers for the detection of malignant tumors that are remote from the oral cavity |
Q33767325 | Salmonella and Shigella species. |
Q26860903 | Salmonella, Shigella, and yersinia |
Q38075159 | Satisfying regulatory and accreditation requirements for quality control |
Q35122342 | Scrapie and chronic wasting disease |
Q38847004 | Screening and Testing in Multiples |
Q37773671 | Screening and testing in multiples |
Q38847028 | Screening for Open Neural Tube Defects |
Q38021111 | Screening for cervical cancer and human papilloma virus: Indian context |
Q38609008 | Screening for high blood cholesterol. |
Q37773677 | Screening for open neural tube defects |
Q69544184 | Screening the healthy subject |
Q34755505 | Selected endocrine test strategies |
Q40266462 | Selected hemostatic abnormalities associated with neoplastic disease. |
Q40703544 | Selected topics in point-of-care testing. Urinalysis, pregnancy testing, microbiology, fecal occult blood, and other tests |
Q43258758 | Selected topics in point-of-care testing: whole blood creatinine, influenza testing, fetal fibronectin and patient self-testing in the home |
Q40935842 | Selected vascular lesions of the placenta |
Q69544198 | Selecting instrumentation for physician's office testing |
Q38724952 | Selection and Implementation of New Information Systems |
Q71098440 | Selection of reference laboratory services |
Q89488259 | Self-Ordering Laboratory Testing: Limitations When a Physician Is not Part of the Model |
Q51808957 | Sentinel Lymph Nodes in Cutaneous Melanoma. |
Q37872869 | Sentinel lymph nodes in cutaneous melanoma |
Q40108742 | Septicemia and Lung Injury |
Q41461093 | Sequence-based diagnosis of hemoglobinopathies in the clinical laboratory. |
Q28238179 | Serine protease inhibitor kazal type 1 mutations and pancreatitis |
Q41605554 | Serodiagnosis of celiac disease |
Q91021892 | Serologic Diagnosis of Rheumatoid Arthritis |
Q40891591 | Serologic evaluation of renal status |
Q39684995 | Serologic testing of human immunodeficiency virus infection. |
Q38730456 | Serum enzymes in disease of skeletal muscle |
Q37761787 | Setbacks in blood substitutes research and development: a biochemical perspective |
Q37961241 | Sex chromosomes and sex chromosome abnormalities |
Q34032528 | Sex steroids and osteoporosis. The role of estrogens and androgens |
Q93534664 | Sexually transmitted diseases |
Q51330150 | Sexually transmitted infections. |
Q38500662 | Shiga Toxin Producing Escherichia coli |
Q37761776 | Shiga toxin-producing Escherichia coli (STEC). |
Q40252110 | Short-term serial testing: functions and analytic methods |
Q71919369 | Should we do another test? Decision making in blood banking |
Q38983525 | Sigma Metrics Across the Total Testing Process |
Q91310601 | Signaling Molecules in Posttransplantation Cancer |
Q69899683 | Simple and rapid methods for bacterial identifications |
Q40225426 | Simulation-based analysis of fluid flow and electrokinetic phenomena in microfluidic devices |
Q41461067 | Simultaneous multianalyte nucleic acid detection for gastrointestinal bacterial pathogens using GeneSTAR technology. |
Q39116164 | Six Sigma Quality Management System and Design of Risk-based Statistical Quality Control |
Q41605546 | Sjögren's syndrome. Controversies and progress |
Q38847040 | Sleep Disordered Breathing and Adverse Pregnancy Outcomes |
Q70169705 | Small-cell pediatric tumors: histology, immunohistochemistry, and electron microscopy |
Q51808926 | Soft Tissue Tumors of Uncertain Histogenesis: A Review for Dermatopathologists. |
Q68942781 | Soft-tissue tumors |
Q37961265 | Solid tumor cytogenetics: current perspectives |
Q38186257 | Soluble ST2 and galectin-3 in heart failure |
Q97900029 | Something's Lost and Something's Gained: Seeing Reference Laboratory Quality from Both Sides, Now |
Q90985807 | Special Considerations for Liquid Chromatography-Tandem Mass Spectrometry Method Development |
Q35178927 | Special Issues in Transfusion Medicine |
Q33854450 | Special stains in the diagnosis of acute leukemia |
Q38186261 | Special topics: cardiac markers in myocarditis: cardiac transplant rejection and conditions other than acute coronary syndrome |
Q38724930 | Specialized Laboratory Information Systems |
Q36874177 | Specialized imaging techniques |
Q41687638 | Spectrum of ischemic heart disease and the role of biochemical markers |
Q37872871 | Spitz nevi, atypical spitzoid neoplasms, and spitzoid melanoma |
Q39496501 | Spot hybridization for the detection of adenoviruses and enteroviruses |
Q36655564 | Standard lipid profile |
Q38642365 | Standardization of antimicrobial susceptibility testing |
Q37761781 | Staphylococcus aureus: An old pathogen with new weapons |
Q38983528 | State-of-the-art Approach to Goal Setting |
Q33948278 | Statistical issues in human papillomavirus testing and screening |
Q50878816 | Statistical quality control procedures. |
Q35780743 | Steroid hormones: relevance and measurement in the clinical laboratory |
Q41136705 | Strategies and logistical requirements for efficient testing in genetic disease |
Q129464353 | Strategies for Clinical Laboratory Management: Contributing Editor’s Comment |
Q38846981 | Strategies for Implementing Cell-Free DNA Testing |
Q40480574 | Strategies for Quality Management in Clinical Microbiology |
Q40252104 | Strategies for communicating the value and limitations of endocrine tests. |
Q50140504 | Strengthening Laboratory Management Toward Accreditation, A Model Program for Pathology Laboratory Improvement |
Q36238993 | Structural and Biologic Properties of Integrin-Mediated Cell Adhesion |
Q74616649 | Sudden natural death in infants and young children |
Q39116125 | Sunway Medical Laboratory Quality Control Plans Based on Six Sigma, Risk Management and Uncertainty |
Q40935813 | Surgical pathology of the uterine cervix. Diagnostic problems and controversies. |
Q40252118 | Surveillance of test use. |
Q44921420 | Susceptibility of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 17 oral antimicrobial agents based on pharmacodynamic parameters: 1998-2001 U S Surveillance Study |
Q38642382 | Susceptibility testing of anaerobic bacteria |
Q38272916 | Susceptibility testing of herpes viruses |
Q70639084 | Symposium on blood banking and hemotherapy |
Q71704528 | Symposium on computers in the clinical laboratory |
Q71388845 | Symposium on controversies in laboratory medicine |
Q93670781 | Symposium on cost containment in the laboratory |
Q70615949 | Symposium on environmental and occupational health hazards |
Q71033659 | Symposium on forensic pathology |
Q71098431 | Symposium on laboratory management |
Q70509702 | Symposium on laboratory measurements in malignant disease |
Q93613255 | Symposium on nucleic acid probes and monoclonal antibodies in the diagnosis of infectious diseases |
Q71120053 | Symposium on perinatal diagnosis |
Q70449379 | Symposium on respiratory infections |
Q71120034 | Symposium on technology assessment |
Q70561843 | Symposium on test selection strategies |
Q71120059 | Symposium on therapeutic drug monitoring |
Q71140918 | Symposium on tissue immunopathology |
Q64129473 | Syphilis |
Q71704533 | System reliability. Assurance of quality and security |
Q38020612 | Systems used to study the nature of the leukemic cell and predict treatment outcome in patients with myeloproliferative disorders. |
Q39485605 | T-cell gene rearrangements and the diagnosis of T-cell neoplasms. |
Q39467404 | T-cell lymphomas and leukemias of post-thymic differentiation |
Q35264797 | Tay-Sachs disease as a model for screening inborn errors |
Q36843134 | Teaching medical students basic principles of laboratory medicine |
Q93013080 | Technical Aspects of Crossmatching in Transplantation |
Q46017750 | Technical and clinical aspects of spectrometric analysis of trace elements in clinical samples. |
Q37942252 | Technical aspects of quantification of aluminum |
Q35264809 | Technical progress in parentage analysis |
Q91619924 | Technical, Biological, and Systems Barriers for Molecular Clinical Decision Support |
Q71120046 | Technology assessment in laboratory medicine: rationalizing or rationing? |
Q36874172 | Telemedicine and telepathology |
Q33948283 | Telomerase, cervical cancer, and human papillomavirus |
Q30445402 | Temporal data mining |
Q34755446 | Test strategies for the detection of myocardial damage |
Q40252097 | Test strategies in selected clinical problems. |
Q91021936 | Testing Immune-Related Adverse Events in Cancer Immunotherapy |
Q40559551 | Testing at the patient's bedside. |
Q34275956 | Testing for cardiac markers at the point of care |
Q35171683 | Testing for fetal lung maturation: a biochemical "window" to the developing fetus |
Q35171700 | Testing for gestational diabetes |
Q35171674 | Testing for hematologic disorders and complications |
Q30882260 | Testing for human papillomavirus: data driven implications for cervical neoplasia management |
Q35171678 | Testing for risk of preterm delivery |
Q42089719 | The "stat" problem |
Q36843106 | The American Society for Clinical Pathology resident in-service examination: does resident performance provide insight into the effectiveness of clinical pathology education? |
Q35560073 | The Bethesda System 2001: an update of new terminology for gynecologic cytology |
Q40112435 | The Carcinoid Syndrome: Neuroendocrine and Chemical Considerations |
Q38266446 | The Centers for Disease Control-National Heart, Lung and Blood Institute Lipid Standardization Program. An approach to accurate and precise lipid measurements |
Q95309610 | The Clinical Application of RNA Sequencing in Genetic Diagnosis of Mendelian Disorders |
Q70217823 | The Contributions of Electron Microscopy in the Diagnosis and Histogenesis of Controversial Neoplasms |
Q97900026 | The Development of New Diagnostic Tests for Neurologic Disorders in the Commercial Laboratory Environment |
Q40480550 | The Diagnosis of Old and New Gastrointestinal Parasites |
Q59700022 | The Diagnostic Assessment of Canine Lymphoma: Implications for Treatment |
Q40386574 | The Ehrlich-Chenzinsky-Plehn-Malachowski-Romanowsky-Nocht-Jenner-May-Grünw ald-Leishman-Reuter-Wright-Giemsa-Lillie-Roe-Wilcox stain. The mystery unfolds |
Q89488276 | The Ethics of Direct-to-Consumer Testing |
Q95309614 | The Evolution of Constitutional Sequence Variant Interpretation |
Q35178951 | The Fourth Dimension: Management of the Postmodern Clinical Laboratory |
Q95309653 | The Future of Clinical Diagnosis: Moving Functional Genomics Approaches to the Bedside |
Q91021945 | The Future of Clinical Immunology Laboratory Testing |
Q38832267 | The Future of Precision Medicine in Oncology |
Q39639896 | The HLA histocompatibility system in autoimmune states |
Q38643440 | The Immunology of Melanoma |
Q89488267 | The Impact of Direct-to-Consumer Genetic Testing on Patient and Provider |
Q129466257 | The Influence of HIA and ABO Antigens on Graft Rejection and Survival |
Q70250077 | The Laboratory Computer as a Management Tool |
Q40480544 | The Laboratory Diagnosis of Mycobacterial Diseases: Challenges and Common Sense |
Q40480527 | The Laboratory Diagnosis of Pneumonia: The Role of the Community Hospital Pathologist |
Q40079483 | The Laboratory Evaluation of Osteopenia |
Q70300130 | The Law, Regulations, and the Clinical Laboratory |
Q36843139 | The MD/PhD pathway to a career in laboratory medicine |
Q38609021 | The National Cholesterol Education Program |
Q38609036 | The National Reference System for Cholesterol |
Q38847026 | The Past, Present, and Future of Preimplantation Genetic Testing |
Q38832270 | The Pharmacist's Perspective on Pharmacogenetics Implementation |
Q51846528 | The Promise and Reality of Pharmacogenetics in Psychiatry |
Q91310621 | The Role of Costimulatory Pathways in Transplant Tolerance |
Q93013163 | The Role of Human Leukocyte Antigen in Celiac Disease Diagnostics |
Q36587045 | The Role of Natural Coagulation Inhibitors in Hemostasis |
Q40480571 | The Use of Molecular Techniques in the Epidemiology and Control of Infectious Diseases |
Q36239008 | The Workload Recording Method: A Laboratory Management Tool |
Q33854481 | The acute erythroleukemias. |
Q40559547 | The advance of technology as a prelude to the laboratory of the twenty-first century. |
Q51533108 | The analysis of native proteins and peptides in the clinical lab using mass spectrometry. |
Q39464104 | The antihypertensive agents: clinical pharmacology and therapeutic monitoring |
Q40544880 | The antiphospholipid and thrombosis (APL-T) syndromes. Clinical and laboratory correlates. |
Q71098444 | The application of measurement systems in the management of medical laboratories |
Q37919295 | The application of monoclonal antibodies in the cytologic evaluation of tumors |
Q70615953 | The behavior of toxic compounds in the environment |
Q40817264 | The beleaguered band count. |
Q38186256 | The benefits of a rapid, point-of-care "TnI-Only" zero and 2-hour protocol for the evaluation of chest pain patients in the Emergency Department |
Q40118397 | The biochemistry of coagulation. |
Q38020599 | The biology of myelopoiesis |
Q39639875 | The central nervous system--immune system relationship |
Q39590406 | The cerebrospinal fluid proteins in multiple sclerosis |
Q36433105 | The changing indications of gastrointestinal decontamination in poisonings |
Q27021779 | The changing landscape of the vaginal microbiome |
Q39740928 | The clinical use of alkaline phosphatase enzymes |
Q41605526 | The clinical utility of antihistone antibodies. Autoantibodies reactive with chromatin in systemic lupus erythematosus and drug-induced lupus. |
Q70561847 | The consequences of false-positive and false-negative errors in medical diagnosis |
Q40246666 | The contribution of immunologic methods to the classification of leukemias and malignant lymphomas. |
Q37908056 | The current status of the diagnosis of chlamydial respiratory infections |
Q40631522 | The cytotoxic T-lymphocyte response in HIV-1 infection |
Q37147374 | The dangers of false-positive and false-negative test results: false-positive results as a function of pretest probability |
Q39829630 | The detection of streptococcal antigens using monoclonal antibodies |
Q30445399 | The development of health care data warehouses to support data mining |
Q33779531 | The effect of benchmarking clinical practice with the clinical laboratory. An institutional case study |
Q71388851 | The efficacy of the autopsy in medical quality assurance |
Q34381255 | The emerging impact of genomics on the development of biological weapons. Threats and benefits posed by engineered extremophiles |
Q41101401 | The epidemiology of hepatitis viruses B, C, and D. |
Q37836015 | The equine neonatal intensive care laboratory: point-of-care testing |
Q37961247 | The evolving picture of microdeletion/microduplication syndromes in the age of microarray analysis: variable expressivity and genomic complexity |
Q40192020 | The extrinsic system. |
Q41432024 | The fifth-year controversy |
Q39868102 | The future of blood management |
Q36322460 | The future prospect: ductoscopy-directed brushing and biopsy |
Q34624820 | The genetic predisposition and the interplay of host genetics and gut microbiome in Crohn disease |
Q34163884 | The genetics of cutaneous melanoma |
Q34032520 | The genetics of osteoporosis. Future diagnostic possibilities |
Q36843088 | The goals of resident training in laboratory medicine in combined anatomic pathology/clinical pathology programs: an overview. |
Q33685785 | The histiocytoses |
Q34163880 | The histologic diagnosis of melanoma. |
Q37628141 | The human bocaviruses: a review and discussion of their role in infection |
Q49302118 | The identification of fungal casts. A new method for diagnosing visceral candidiasis |
Q28238190 | The impact of cystic fibrosis and PSTI/SPINK1 gene mutations on susceptibility to chronic pancreatitis |
Q30304479 | The impact of diagnostic immunohistochemistry on patient outcomes |
Q37332949 | The impact of immune gene polymorphisms in kidney and liver transplantation. |
Q33779513 | The impact of molecular diagnostic tests on patient outcomes |
Q34625008 | The impact of proton pump inhibitors on the human gastrointestinal microbiome |
Q39589509 | The impact of reimbursement changes on doctors' office testing. |
Q38005552 | The importance of calcium regulation in toxic cell injury. Studies utilizing the technology of digital imaging fluorescence microscopy. |
Q37435509 | The influence of HLA and ABO antigens on graft rejection and survival |
Q33685763 | The influence of developmental haemostasis on the laboratory diagnosis and management of haemostatic disorders during infancy and childhood. |
Q38244378 | The influence of various patient characteristics on D-dimer concentration in critically ill patients and its role as a prognostic indicator in the intensive care unit setting. |
Q37733313 | The ins and outs of laboratory information systems. Combining the hospital and reference laboratory |
Q34624786 | The interrelationships of the gut microbiome and inflammation in colorectal carcinogenesis |
Q36976846 | The laboratory and patient safety |
Q34996352 | The laboratory approach to inherited and acquired coagulation factor deficiencies |
Q34755490 | The laboratory evaluation of platelet dysfunction |
Q35957839 | The laboratory is a key partner in assuring patient safety |
Q34381232 | The laboratory role in diagnosis of infections transmitted by arthropods |
Q35560083 | The many faces of atrophy in gynecologic cytology |
Q70639098 | The mechanisms of destruction of antibody-altered cells |
Q37902559 | The molecular biology of acute myeloid leukemia. Proto-oncogene expression and function in normal and neoplastic myeloid cells. |
Q40929183 | The mycobacteriology laboratory. Past, present, and future |
Q40817222 | The mystique of the erythrocyte sedimentation rate. A reappraisal of one of the oldest laboratory tests still in use. |
Q38609013 | The need for accurate total cholesterol measurement. Recommended analytical goals, current state of reliability, and guidelines for better determinations |
Q33690220 | The neurobiology of anxiety disorders: brain imaging, genetics, and psychoneuroendocrinology |
Q35869006 | The new mycobacterial species--emerging or newly distinguished pathogens |
Q40817270 | The nuances of lymphocytopenia |
Q35465203 | The oral microbiome and oral cancer |
Q52695261 | The pathologist and the diagnostic process. With a note on Edelman's Group Selection Theory and the Darwinian Computer. |
Q40817282 | The pathologist as a clinical consultant for hemostasis in the community hospital. |
Q41550541 | The pathologist's workstation. |
Q37435640 | The pathology of regulation. |
Q41729724 | The pathology of terrorism. Acts of violence directed against citizens of the United States while abroad. |
Q37147386 | The physician quality reporting initiative |
Q34118215 | The platelet storage lesion |
Q37919293 | The potential role of physicians in the management of hospital information systems |
Q38039687 | The prescription drug abuse epidemic |
Q39829639 | The production of monoclonal antibodies against respiratory syncytial virus and its clinical applications |
Q40817216 | The red cell indices. Yesterday, today, and tomorrow. |
Q46444323 | The regenerative medicine laboratory: facilitating stem cell therapy for equine disease |
Q68034317 | The regulation of medical laboratories in Australia |
Q35780776 | The role and assessment of ventricular peptides in heart failure |
Q46634156 | The role of copper, molybdenum, selenium, and zinc in nutrition and health. |
Q36894049 | The role of flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria in the clinical laboratory. |
Q77802855 | The role of gas chromatography/mass spectrometry. Instrumental techniques in forensic urine drug testing |
Q37885397 | The role of molecular diagnostics in the clinical microbiology laboratory. |
Q40267441 | The role of new laboratory tests in clinical decision-making |
Q38020610 | The role of ras gene mutations in myeloproliferative disorders |
Q37773673 | The role of second-trimester serum screening in the post-first-trimester screening era. |
Q77802885 | The role of the EAP in the identification and treatment of substance abuse |
Q69544205 | The role of the clinical pathologist in physician's office testing |
Q69544181 | The role of the hospital laboratory and its personnel in doctor's office testing |
Q81471235 | The role of the medical laboratory director |
Q74616635 | The scope of forensic radiology |
Q34163921 | The shifting patterns of metastatic melanoma |
Q39799699 | The state of quality control: a critique. |
Q38609001 | The status of hypertriglyceridemia as a risk factor for coronary heart disease. |
Q77316009 | The surgical pathologist's approach to fine needle aspiration |
Q35815411 | The technology, law, and ethics of in vitro fertilization, gamete donation, and surrogate motherhood |
Q39868120 | The three "R"s of blood transfusion in 2020; routine, reliable and robust |
Q34032555 | The treatment of osteoporosis. Antiresorptive therapy |
Q70639088 | The type and antibody screen |
Q39507886 | The ultrastructure of selected gynecologic neoplasms |
Q41161234 | The underlying molecular mechanism of apolipoprotein E polymorphism: relationships to lipid disorders, cardiovascular disease, and Alzheimer's disease. |
Q80116224 | The use of a dual dye photometric calibration method to identify possible sample dilution from an automated multichannel liquid-handling system |
Q35780763 | The use of biochemical markers in osteoporosis |
Q36618834 | The use of cytochemical procedures in the diagnosis and management of acute and chronic myeloid leukemia |
Q40196400 | The use of cytogenetic techniques for the diagnosis of endocrine diseases |
Q40252091 | The use of discriminant analysis and other multivariate statistical methods for the identification of efficient combinations of laboratory tests. |
Q41876718 | The use of electron microscopy and immunohistochemistry in the diagnosis and understanding of lung neoplasms |
Q34755573 | The use of expert systems for improving test use and enhancing the accuracy of diagnosis |
Q34755559 | The use of ordering protocols and other maneuvers: the Canadian experience |
Q70670727 | The use of synthetic substrates in the coagulation laboratory |
Q36105151 | The usefulness of immunohistochemical markers in the differential diagnosis of renal neoplasms |
Q38039693 | The utility of immunoassays for urine drug testing |
Q37342113 | The value of CYP2D6 and OPRM1 pharmacogenetic testing for opioid therapy |
Q30728356 | The virtual blood film |
Q34122155 | The wright-giemsa stain. Secrets revealed |
Q38730427 | Theoretical aspects of enzymes in diagnosis. Why do serum enzymes change in hepatic, myocardial, and other diseases? |
Q95309648 | Therapeutic Gene Editing with CRISPR: A Laboratory Medicine Perspective |
Q35122351 | Therapeutic approaches to prion diseases. |
Q41159626 | Therapeutic drug monitoring of the antimycobacterial drugs. |
Q40335939 | Therapeutic drug monitoring of theophylline, salicylates, and acetaminophen. |
Q69396206 | Therapeutic drug monitoring--II: Patient care and applications |
Q69124727 | Therapeutic drug monitoring. I: Pharmacokinetics, technology, and methodology |
Q71120065 | Therapeutic drug monitoring. Pharmacokinetic and pharmacodynamic principles |
Q71846741 | Therapeutic hemapheresis |
Q40393204 | Therapy Other Than Reverse Transcriptase Inhibitors for HIV Infection |
Q38182221 | Therapy of human immunodeficiency virus infections |
Q33854467 | Therapy-related acute leukemia |
Q34163900 | Thin melanomas |
Q40819900 | Thoughts on quality for pathology |
Q35122356 | Three-dimensional structures of the prion protein and its doppel |
Q33385719 | Thrombotic thrombocytopenic purpura and heparin-induced thrombocytopenia: two unique causes of life-threatening thrombocytopenia |
Q35780725 | Thyroglobulin: a specific serum marker for the management of thyroid carcinoma |
Q40772977 | Thyroid cancer diagnosis and management. |
Q35780720 | Thyroid disease: pathophysiology and diagnosis |
Q40772937 | Thyroid hormone transport proteins. |
Q40772972 | Thyroid imaging techniques. |
Q39273192 | Tick-Borne Emerging Infections: Ehrlichiosis and Anaplasmosis |
Q84332788 | Tick-borne flaviviruses |
Q54716603 | Tickborne Borrelia Infections: Beyond Just Lyme Disease. |
Q43258762 | Tight glycemic control and point-of-care testing |
Q52713103 | Timing of repeated monitoring tests. |
Q36243585 | Tissue banking overview |
Q36243588 | Tissue banking regulations and oversight |
Q78046173 | To serve or listserv. Stresses from the field |
Q92427156 | Total Laboratory Automation: What Is Gained, What Is Lost, and Who Can Afford It? |
Q51808952 | Toward a Molecular-Genetic Classification of Spitzoid Neoplasms. |
Q34505939 | Toxicity associated with carbon monoxide |
Q77802889 | Toxicology and adverse effects of drugs used for immunosuppression in organ transplantation |
Q38005554 | Toxicology and biocompatibility considerations in the evaluation of polymeric materials for biomedical applications |
Q43632351 | Toxicology and drugs of abuse testing at the point of care |
Q39008421 | Toxicology in Addiction Medicine |
Q39008413 | Toxicology in Pain Management |
Q39008436 | Toxicology in Reproductive Endocrinology |
Q84912481 | Toxicology testing |
Q38039696 | Toxicology testing in alternative specimen matrices |
Q42689029 | Toxicosis caused by melamine and cyanuric acid in dogs and cats: uncovering the mystery and subsequent global implications |
Q34385312 | Toxins as weapons of mass destruction. A comparison and contrast with biological-warfare and chemical-warfare agents |
Q36525326 | Toxins: bacterial and marine toxins |
Q38847033 | Toxoplasmosis, Parvovirus, and Cytomegalovirus in Pregnancy |
Q37773676 | Toxoplasmosis, parvovirus, and cytomegalovirus in pregnancy |
Q71033697 | Trace evidence and the pathologist |
Q91619937 | Training Aspects of Laboratory-Based Decision Support |
Q38724959 | Training in Informatics: Teaching Informatics in Surgical Pathology |
Q36843125 | Training in laboratory management and the MBA/MD in laboratory medicine |
Q50140476 | Training the Next Generation of African Pathologists. |
Q71649644 | Transfusing the patient with autoimmune hemolytic anemia |
Q40845899 | Transfusion reactions. Status in 1982. |
Q52723973 | Transfusion-transmitted viral hepatitis. |
Q33329448 | Transient myeloproliferative disorder (transient leukemia) and hematologic manifestations of Down syndrome. |
Q38724956 | Translational Bioinformatics and Clinical Research (Biomedical) Informatics. |
Q36105174 | Translocation carcinomas of the kidney |
Q35122337 | Transmissible spongiform encephalopathy update and implications for blood safety |
Q41729711 | Traumatic neuropathology. |
Q38244368 | Treatment and long-term management of venous thromboembolism |
Q38182223 | Treatment of cytomegalovirus infection |
Q45847830 | Treatment of herpes simplex virus infections. |
Q33948294 | Treatment of human papillomavirus gynecologic infections |
Q38244372 | Treatment of intracerebral hemorrhage associated with new oral anticoagulant use: the neurologist's view |
Q39684999 | Treatment of varicella-zoster virus infections |
Q40335936 | Tricyclic antidepressants and lithium. |
Q38609003 | Triglyceride measurement and its relationship to heart disease |
Q41687651 | Troponin, where do we go from here? |
Q41159618 | Tuberculosis bacteriology laboratory services and incremental protocols for developing countries |
Q38021106 | Tuberculosis: laboratory diagnosis |
Q36105181 | Tubulocystic carcinoma, mucinous tubular and spindle cell carcinoma, and other recently described rare renal tumors |
Q40246658 | Tumor markers for breast carcinoma |
Q68766966 | Tumor markers in diagnostic pathology |
Q37586249 | Tumor markers in endocrine malignancies. |
Q37919278 | Tumor markers in gynecologic neoplasms |
Q42522133 | Tumors of Schwann's cells and pigmented skin cells |
Q68942785 | Tumors of serosal tissue origin |
Q68942790 | Tumors of the alimentary tract |
Q43491700 | Tumors of the liver, extrahepatic biliary tract, and pancreas |
Q38053214 | Twenty-first century pathology sign-out |
Q38021113 | Type 2 diabetes in Asian Indians |
Q39116113 | Uncertainty in Measurement and Total Error: Tools for Coping with Diagnostic Uncertainty |
Q34231451 | Uncontrolled diabetes mellitus. |
Q38005547 | Understanding digoxin use in the elderly patient |
Q38924947 | Understanding the Food and Drug Administration's Jurisdiction Over Laboratory-Developed Tests and Divisions Between Food, Drug, and Cosmetic Act-Regulated and Clinical Laboratory Improvement Amendments of 1988-Regulated Activities |
Q38983530 | Understanding the Use of Sigma Metrics in Hemoglobin A1c Analysis |
Q33767345 | Unusual food-borne pathogens. Listeria monocytogenes, Aeromonas, Plesiomonas, and Edwardsiella species. |
Q101119147 | Update in Infectious Disease Diagnosis in Anatomic Pathology |
Q101119135 | Update in Pediatric Diagnostic Microbiology |
Q35999815 | Update of autoantibodies in neurologic disease |
Q30655571 | Update of diagnostic and prognostic markers in cutaneous malignant melanoma |
Q101119132 | Update on Biosafety and Emerging Infections for the Clinical Microbiology Laboratory |
Q91021948 | Update on Clinical Immunology Laboratory Testing |
Q40085184 | Update on Merkel Cell Carcinoma. |
Q101119125 | Update on Susceptibility Testing: Genotypic and Phenotypic Methods |
Q35999796 | Update on autoantibodies to intracellular antigens in systemic rheumatic diseases |
Q37886510 | Update on laboratory diagnosis of sexually transmitted diseases |
Q40963323 | Update on the Human Genome Project |
Q40935806 | Update on the surgical pathology of the vulva. |
Q67928233 | Urinalysis |
Q40891512 | Urinalysis and urinary sediment in patients with renal disease |
Q39525578 | Urinalysis in the diagnosis of urinary tract infections |
Q68965687 | Urinalysis: its proper role in the physician's office |
Q39525556 | Urinary parameters to assess renal function |
Q38214184 | Urine antigen tests for the diagnosis of respiratory infections: legionellosis, histoplasmosis, pneumococcal pneumonia |
Q69124733 | Urine drug screening by gas chromatography-mass spectrometry. Application to a pediatric environment |
Q38039688 | Urine drug testing for pain management |
Q77802879 | Urine drug testing for social service agencies. A Canadian experience |
Q40881358 | Urticaria, angioedema, and autoimmunity |
Q41461054 | Use of DNA polymorphisms to monitor engraftment after allogeneic bone marrow transplantation |
Q129461542 | Use of Immunologic Tumor Makers in Body Fluid Analysis |
Q38571527 | Use of Lactate in Small Animal Clinical Practice |
Q36491817 | Use of comprehensive laboratory data as a management tool |
Q31033566 | Use of flow and laser scanning cytometry to study mechanisms regulating cell cycle and controlling cell death. |
Q39827241 | Use of immunologic tumor markers in body fluid analysis |
Q40252085 | Use of methods of pattern recognition to assist in test selection and test interpretation |
Q39829635 | Use of monoclonal antibodies in the diagnosis and epidemiologic studies of legionellosis |
Q37904045 | Use of nonradioactive DNA probes for the detection of infectious bacteria |
Q38108946 | Use of oral hypoglycemic and insulin agents in pregnant patients |
Q40246662 | Use of pancreas-specific antigen in immunodiagnosis of pancreatic cancer. |
Q36463597 | Use of patient data for quality control |
Q36445148 | Use of the APAAP method in the classification and diagnosis of hematologic disorders |
Q39008472 | Use of the Clinical Laboratory in Psychiatric Practice |
Q35815382 | Use of the laboratory in infertility and recurrent spontaneous miscarriage |
Q69588695 | Usefulness of immunofixation electrophoresis in the clinical laboratory |
Q40817276 | Usefulness of the mean platelet volume. |
Q71704545 | User design of a laboratory computer system |
Q39162300 | Uses of immune globulins in the prophylaxis and treatment of viral infections |
Q38571525 | Using Cardiac Biomarkers in Veterinary Practice |
Q39116142 | Using Sigma Quality Control to Verify and Monitor Performance in a Multi-Instrument, Multisite Integrated Health Care Network |
Q34755585 | Using Web technologies for implementing testing strategies |
Q51029325 | Using a microcantilever array for detecting phase transitions and stability of DNA. |
Q70561850 | Using multiple tests: series and parallel approaches |
Q37733316 | Using the laboratory information system to achieve strategic advantage over the competitors of hospital-based clinical laboratories. |
Q41687616 | Utility of cardiac troponins in patients with suspected cardiac trauma or after cardiac surgery |
Q37628135 | Utilization of nucleic acid amplification assays for the detection of respiratory viruses |
Q36433108 | Utilizing the laboratory in the poisoned patient |
Q38695505 | Vaginitis/vaginosis |
Q38075163 | Validating the performance of QC procedures |
Q67946625 | Value and limitations of cytologic examinations |
Q35792482 | Vancomycin resistance in Staphylococcus aureus |
Q59691608 | Variant Creutzfeldt-Jakob disease |
Q34165658 | Variant Creutzfeldt-Jakob disease and bovine spongiform encephalopathy. |
Q38353390 | Verification and standardization of blood cell counters for routine clinical laboratory tests |
Q51029330 | Verifying liquid-handler performance for complex or nonaqueous reagents: a new approach. |
Q46069866 | Veterinary laboratory medicine. Preface |
Q33767340 | Vibrio species. |
Q38500669 | Vibriosis |
Q36525319 | Viral hemorrhagic fevers |
Q35029094 | Viral hemorrhagic fevers including hantavirus pulmonary syndrome in the Americas |
Q84442607 | Viral hepatitis in India |
Q129440109 | Vitamin D Assessment: The Assays and Their Applications |
Q50140509 | Voices from the Field: Interviews with Global Health Pathology Volunteers |
Q40112108 | Von Willebrand's disease. Clinical picture, diagnosis, and treatment |
Q89488269 | Wave of Wearables: Clinical Management of Patients and the Future of Connected Medicine |
Q92427207 | We Cannot Do It Alone: The Intersection of Public Health, Public Policy, and Clinical Microbiology |
Q40819889 | Wellness testing. Design and experience of an established program |
Q54050362 | West Nile Virus. |
Q56932479 | West Nile virus |
Q92427213 | What Is the Future of Clinical Microbiology? |
Q35815440 | What can be learned from cordocentesis? |
Q92427195 | What the Clinical Microbiologist Should Know About Pharmacokinetics/Pharmacodynamics in the Era of Emerging Multidrug Resistance: Focusing on β-Lactam/β-Lactamase Inhibitor Combinations |
Q92427145 | When One Drug Is Not Enough: Context, Methodology, and Future Prospects in Antibacterial Synergy Testing |
Q35560088 | White blood cell counts: reference methodology |
Q41687644 | Why cardiospecificity is preeminent in myocardial markers of injury |
Q69544177 | Why office testing? |
Q37336723 | Why spend the money? Justification of laboratory information systems |
Q67999572 | Workflow analysis in determining instrumentation needs |
Q38053212 | Workflow organization in pathology |
Q50140495 | World Health Organization List of Priority Medical Devices for Cancer Management to Promote Universal Coverage |
Q71033667 | Wounds caused by centerfire rifles |
Q74616632 | Wounds from civilian and military centerfire rifles |
Q34118209 | Yellow fever: a reemerging threat |
Q129470841 | Yersinia Enterocolitica and Yersinia Pseudotuherculosis |
Q33767337 | Yersinia enterocolitica and Yersinia pseudotuberculosis |
Q37332953 | Yin and yang of cytokine regulation in solid organ graft rejection and tolerance |
Q29994543 | Zika Virus |
Q35335688 | alpha-fetoprotein and screening markers of congenital disease |
Q35178916 | leukocyte-reduced blood components in transfusion medicine: Current Indications and Prospects for the Future |
Search more.